ORIGINAL RESEARCH article

Front. Microbiol., 24 December 2018

Sec. Infectious Agents and Disease

Volume 9 - 2018 | https://doi.org/10.3389/fmicb.2018.03183

Iron Regulation in Clostridioides difficile

  • 1. Braunschweig Integrated Centre of Systems Biology (BRICS), Technische Universität Braunschweig, Braunschweig, Germany

  • 2. Center for Functional Genomics of Microbes (CFGM), Institute of Microbiology, University of Greifswald, Greifswald, Germany

  • 3. Department of Molecular Infection Biology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany

  • 4. Central Facility for Microscopy, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany

  • 5. Institute of Microbiology, Technische Universität Braunschweig, Braunschweig, Germany

  • 6. Leibniz-Institute DSMZ–German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany

Abstract

The response to iron limitation of several bacteria is regulated by the ferric uptake regulator (Fur). The Fur-regulated transcriptional, translational and metabolic networks of the Gram-positive, pathogen Clostridioides difficile were investigated by a combined RNA sequencing, proteomic, metabolomic and electron microscopy approach. At high iron conditions (15 μM) the C. difficile fur mutant displayed a growth deficiency compared to wild type C. difficile cells. Several iron and siderophore transporter genes were induced by Fur during low iron (0.2 μM) conditions. The major adaptation to low iron conditions was observed for the central energy metabolism. Most ferredoxin-dependent amino acid fermentations were significantly down regulated (had, etf, acd, grd, trx, bdc, hbd). The substrates of these pathways phenylalanine, leucine, glycine and some intermediates (phenylpyruvate, 2-oxo-isocaproate, 3-hydroxy-butyryl-CoA, crotonyl-CoA) accumulated, while end products like isocaproate and butyrate were found reduced. Flavodoxin (fldX) formation and riboflavin biosynthesis (rib) were enhanced, most likely to replace the missing ferredoxins. Proline reductase (prd), the corresponding ion pumping RNF complex (rnf) and the reaction product 5-aminovalerate were significantly enhanced. An ATP forming ATPase (atpCDGAHFEB) of the F0F1-type was induced while the formation of a ATP-consuming, proton-pumping V-type ATPase (atpDBAFCEKI) was decreased. The [Fe-S] enzyme-dependent pyruvate formate lyase (pfl), formate dehydrogenase (fdh) and hydrogenase (hyd) branch of glucose utilization and glycogen biosynthesis (glg) were significantly reduced, leading to an accumulation of glucose and pyruvate. The formation of [Fe-S] enzyme carbon monoxide dehydrogenase (coo) was inhibited. The fur mutant showed an increased sensitivity to vancomycin and polymyxin B. An intensive remodeling of the cell wall was observed, Polyamine biosynthesis (spe) was induced leading to an accumulation of spermine, spermidine, and putrescine. The fur mutant lost most of its flagella and motility. Finally, the CRISPR/Cas and a prophage encoding operon were downregulated. Fur binding sites were found upstream of around 20 of the regulated genes. Overall, adaptation to low iron conditions in C. difficile focused on an increase of iron import, a significant replacement of iron requiring metabolic pathways and the restructuring of the cell surface for protection during the complex adaptation phase and was only partly directly regulated by Fur.

Introduction

Clostridioides difficile (formerly Clostridium difficile) is a spore-forming, Gram-positive, anaerobic, toxins-producing pathogen leading to often hospital-acquired infections worldwide (Burke and Lamont, 2014). The phenotypes of C. difficile infections (CDI) range from mild diarrhea to toxic megacolon which ultimately causes death (Bartlett and Gerding, 2008). In the United States over half a million cases of CDI per year with approximately 30,000 deaths are reported, making CDI to one of the most common and also cost-effective healthcare-associated infections (Lessa et al., 2015). Proteins containing iron, [Fe-S]-clusters and iron-coordinated heme are indispensable for the bacterial metabolism. Consequently, iron is an essential element for the growth of all bacteria including C. difficile (Symeonidis, 2012). Despite its abundance in nature, iron is often a growth-limiting nutrient due to the low solubility of the dominating oxidized ferric iron over the soluble ferric form (Braun and Hantke, 2011). To counteract this problem, bacteria have developed high affinity transporters and high affinity chelators, so called siderophores, which are excreted and re-imported after iron acquisition to cope with this limitation (Huang and Wilks, 2017; Khan et al., 2018). Alternatively, ferric reductases are excreted (Schroder et al., 2003). In pathogenic bacteria these iron-uptake mechanisms acquire iron directly from host proteins, including the iron-binding glycoproteins transferrin in serum and extracellular fluid, lactoferrin in mucosal secretions, and heme-containing proteins such as hemoglobin, haptoglobin, and hemopexin (Symeonidis, 2012). C. difficile can utilize different iron salts (FeCl3, FeSO4), iron citrate and ferritin as iron source (Cernat and Scott, 2012). In a previous investigation ferritin, hemoproteins and heme were able to sustain growth of C. difficile under iron-limited condition (Cernat and Scott, 2012). However, a cellular overload with iron has to be avoided to prevented reactive oxygen species generation via the Fenton reaction (Cornelis et al., 2011). As a consequence, bacteria have evolved various mechanisms to control iron homeostasis. They carefully adjust their iron uptake and utilization strategies at the transcriptional level (Troxell and Hassan, 2013; Porcheron and Dozois, 2015). Several iron-responsive regulatory proteins (Fur, Irr, RirA, and IscR) have been described in bacteria (Rudolph et al., 2006; Santos et al., 2015; Mandin et al., 2016). The ferric uptake regulator (Fur) protein is a transcriptional repressor of genes in iron uptake and utilization (Troxell and Hassan, 2013; Fillat, 2014; Porcheron and Dozois, 2015). The Fur protein typically contains two structural domains, the N-terminal DNA binding domain and the C-terminal dimerization domain (Deng et al., 2015). Under iron-replete conditions, Fe2+ functions as a co-repressor in that the Fur–Fe2+ complex binds a conserved DNA site in the promoter of a regulated gene and usually inhibits the expression. In contrast, under iron starvation conditions, the Fur protein is inactive, which allows for the expression of Fur-regulated genes.

The Fur regulons of Clostridium acetobutylicum and C. difficile were determined using DNA microarray-based transcriptome analyses (Vasileva et al., 2012; Ho and Ellermeier, 2015). In C. difficile one transcriptome investigation focused on high iron versus iron-depleted conditions (Hastie et al., 2018), while the second defined the Fur-regulon under high iron conditions (Ho and Ellermeier, 2015). In C. acetobutylicum genes for various siderophore uptake systems (feo, fhu), a flavodoxin (fldX), lactate dehydrogenase (ldh), benzoyl-CoA reductase and riboflavin biosynthesis (rib) were found under Fur-mediated iron control. A Fur binding site of G/T-A/T-T/G-A-A-T-N-A/T-T/A-T/A- T-C-A-T/A-T/A-A/T was proposed (Vasileva et al., 2012). Similarly, in C. difficile genes for 7 putative cation transport systems including various iron uptake systems (fpi, feo, and fhu,) a flavodoxin (fldX), two component regulatory systems and very few metabolic enzymes were found repressed by Fur in an iron-dependent manner. But also a series of Fur induced genes were identified. Furthermore, in vitro DNA binding by Fur was shown (Ho and Ellermeier, 2015). The deduced Fur binding site was A-A-A-T-G-A-T-A-A-T-N-A-A/T-T/A-A/T-T-C-A. A similar binding site A/T-A/T-N- T/A-N-T-G-A-T-A-A-T-G-A-T-T-T-T-C-A-T-T-A/T was proposed by (Dubois et al., 2016). They demonstrated cysteine-dependent regulation of fur and several fur target genes. Finally, the C. difficile Fur regulon was found induced in a hamster infection model control (Ho and Ellermeier, 2015). During the second DNA-array-based transcriptome approach focusing on iron versus iron-depleted conditions, genes for a flavodoxin, enzymes of polyamine and histidine biosynthesis, and flagella formation were found induced under iron limiting conditions (Hastie et al., 2018). Corresponding studies in Clostridium perfringens identified FeoB as the major systems to counteract iron depletion in this bacterium (Awad et al., 2016). Finally, a bioinformatics investigation proposed the DNA binding site for Clostridium botulinum Fur as A/T-T/A- T-N-A/T-T/A- A-A/T-T-A/T-A-T/A-T/A-A-T-T-A/T-T-T (Zhang et al., 2011). A position weight matrix analyses was employed for regulon prediction.

Here we describe a combined RNA sequencing-based transcriptomic, proteomic, metabolomic and electron microscopy approach to characterize multiple functional and metabolic changes induced by the Fur-mediated low iron response. Multiple cellular processes aside of iron transport including mainly energy metabolism, but also flagella formation and motility, cell wall architecture and antibiotic/CAMP resistance were controlled by iron and partly by Fur in C. difficile.

Materials and Methods

Bacterial Strains and Growth Conditions

Escherichia coli DH5a [fhuA2 lac(del)U169 phoA glnV44 Φ80’ lacZ(del)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17], DH10B [F-mcrA Δ(mrr-hsdRMS-mcrBC) Φ80dlacZΔM15 ΔlacX74 endA1 recA1 deoR Δ(ara,leu)7697 araD139 galU galK nupG rpsL λ-], and CA434 (E. coli HB101 carrying the Incβ conjugative plasmid R702) were grown in LB medium supplemented with 100 mg/l ampicillin or 20 mg/l chloramphenicol as required. C. difficile 630Δerm cells were grown in Brain-Heart-Infusion (BHI) medium (37 g/l) supplemented with 0.1% L-cysteine and 5 mg/ml yeast extract. During mutagenesis experiments C. difficile supplement (250 mg/l D-cycloserine and 8 mg/l cefoxitin) (Sigma Aldrich, Taufkirchen, Germany) and 2.5 mg/l erythromycin (Carl Roth, Karlsruhe, Germany) were added. Growth and Omics experiments were performed in Clostridium difficile minimal medium (CDMM) (Neumann-Schaal et al., 2015) under anaerobic conditions using an anaerobic chamber from Coy Laboratories (Grass Lake, MI, United States). Different iron sources were tested as additives to the medium including 15 μM iron-sulfate, 15 μM iron-chloride, 15 μM iron-citrate, 10 μM hemin, 10 μg/ml ferritin and 10 μg/ml transferrin unless stated otherwise. Cells were harvested (10 min, 8,000 × g) anaerobically using gas-tight polypropylene tubes (TPP, Trasadingen, Switzerland) and harvested cells and/or supernatant were used for transcriptome, proteome and metabolome analyses as described below.

Construction of the C. difficile fur Mutant and a fur Containing Vector for Complementation

The vector for fur inactivation was designed with the help of the ClosTron website1 using the Perutka algorithm (Perutka et al., 2004). E. coli CA434 was transformed with the resulting pMTL007C-E2_fur274a::intron vector (pMTL007C-E2 retargeted to CD630Δerm fur274a::intron, ermB) for mating with C. difficile 630Δerm cells after a standard protocol (Heap et al., 2007, 2009, 2010). The desired fur mutant was identified using primers Cdi-fur-F (5′-CTGGTTTTAAGATTACGCCAC-3′), Cdi-fur-R (5′-CCATTACACTCGTCACATAGTC-3′), EBSuni-versal (5′CGAAATTAGAAACTTGCGTTCAGTAAA-3′), Erm-RAM-RF (5′-ACGCGTTATATTGATAAAAATAATAGTGGG-3′), ErmRAM-R (5′-ACGCGTGCGACTCATAGAATTATTTCCTCCCG-3′) as described and documented in the Supplementary Material. For complementation of the C. difficile fur mutant, a PCR fragment covering the region from 300 bp upstream to 100 bp downstream of the fur gene (CD630_12870) was amplified using chromosomal C. difficile 630 DNA and the primers Cdi-fur-compl.NotI-F (5′-ATCAGCGGCCGCCAGATATTTATTATATTTGC-3′ and Cdi-fur-compl.HindIII-R (5′-ATCAAAGCTTAATGGAAGAATAGCATAG-3′) digested with NotI and HindIII and cloned into the appropriately cut shuttle vector pMTL82151 to generate pMTL82151_fur (Heap et al., 2009).

Field Emission Scanning Electron Microscopy (FESEM)

Clostridioides difficile 630Δerm and corresponding fur mutant were grown anaerobically in CDMM with and without addition of 15 μM iron-sulfate at 37°C to mid-exponential phase, harvested and fixated with 5% formaldehyde. Afterwards, the cells were washed with TE-buffer (20 mM TRIS, 1 mM EDTA, pH 6.9) before dehydration in a graded series of acetone (10, 30, 50, 70, and 90%) on ice for 15 min for each step. The 100% acetone dehydration step was performed at room temperature. Then, samples were critical-point dried with liquid CO2 (CPD 30, Bal-Tec, Balzers, Liechtenstein) and covered with a gold-palladium film by sputter coating (SCD 500, Bal-Tec, Balzers, Liechtenstein) before being examined in a field emission scanning electron microscope (Zeiss DSM 982 Gemini, Oberkochen, Germany) using the Everhart Thornley SE detector and the in lens detector in a 50:50 ratio at an acceleration voltage of 5 kV.

RNA Sequencing

Clostridioides difficile 630Δerm and corresponding fur mutant were grown anaerobically in CDMM with and without addition of 15 μM iron-sulfate at 37°C to mid-exponential phase and harvested. Employed CDMM without additions contained 0.2 μM iron. Due to the different growth behavior of both strains the mid-exponential growth rate was reached by both strains at different time points. At these two time points both strains revealed comparable growth rates. Total bacterial RNA was isolated from bacterial cell pellets as described before (Rosinski-Chupin et al., 2014). Residual DNA was removed using TURBO DNase (Ambion, Thermo Fisher Scientific, Waltham, MA, United States). Resulting DNA-free RNA was further purified with phenol:chloroform:isoamylalcohol (25:24:1) extraction. Remaining traces of phenol were removed by washing the samples twice with chloroform:isoamylalcohol (24:1). RNA integrity was assessed using the Agilent RNA 6000 Nano Kit on the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, United States). Transfer RNA was depleted from the total RNA using Microbexpress (Ambion, Thermo Fisher Scientific, Waltham, MA, United States). To 1 μg of rRNA depleted total RNA 1 μl of either 1:10 diluted ERCC ExFold RNA Spike-In Mix 1 or 2 (Ambion, Thermo Fisher Scientific, Waltham, MA, United States) was added. RNA was subsequently treated with tobacco acid pyrophosphatase (TAP) (Epicentre Biotechnologies, Madison, WI, United States). Prior to cDNA library preparation, RNA was further purified with phenol:chloroform:isoamylalcohol (25:24:1), any remaining phenol traces were removed by washing the samples twice with chloroform:isoamylalcohol (24:1), RNA was recovered by ethanol precipitation. Strand-specific RNA-Seq cDNA library preparation and barcode introduction based on RNA adapter ligation was performed as described previously (Nuss et al., 2015). Library quality was validated using the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, United States) following the manufacturer’s instruction. Cluster generation was performed using the Illumina cluster station. Single-end sequencing on the Illumina HiSeq2500 followed a standard protocol. The fluorescent images were processed to sequences and transformed to FastQ format using the Genome Analyzer Pipeline Analysis software 1.8.2 (Illumina, San Diego, CA, United States). The sequence output was controlled for general quality features. Sequencing adapter clipping and demultiplexing was done using the fastq-mcf and fastq-multxtool of ea-utils2. DNA sequencing output was analyzed using the FastQC tool (Babraham Bioinformatics, Cambridge, United Kingdom). All sequenced libraries were mapped to the C. difficile 630 genome (NC_009089.1) and the corresponding pCD630 plasmid (NC_008226.1) using Bowtie2 (version 2.1.0) (Langmead and Salzberg, 2012) with default parameters. ERCC mapping and analysis were performed after supplier’s instructions. After read mapping, SAMtools (Li et al., 2009) was employed to filter the resulting bam files for uniquely mapped reads (both strands), which were the basis for downstream analyses. Differential gene expression was evaluated using the DESeq2 tool as part of the Bioconductor software package. Throughout the manuscript the data were adapted to the C. difficile 630Δerm annotation. In Table 1 both annotations are given. For the interconversion of the original data shown in Supplementary Tables S1S3 and also the proteomics data in Supplementary Table S4 in the Supplemental Material an appropriate conversion table (Supplementary Table S5) is provided. The data discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus (Edgar et al., 2002) and are accessible through GEO Series accession number GSE120189.

Table 1

GeneWild type: low vs.fur mutant vs. wild typeFur box


Locus_tagnamehigh iron (log2 FC)at high iron (log2 FC)
TPTP
Metal transport systems
CD630_16470 CDIF630erm_01824yclNIron family ABC transporter permease4.790.185.90+
CD630_16480 CDIF630erm_01825yclOIron family ABC transporter permease3.43ON4.74ON
CD630_16490 CDIF630erm_01826yclPIron family ABC transporter ATP-binding protein5.160.625.19ON
CD630_16500 CDIF630erm_01827yclQIron family ABC transporter substrate-binding protein4.987.464.658.55+
CD630_28740 CDIF630erm_03142MATE family drug/sodium antiporter2.424.12
CD630_28750 CDIF630erm_03143fhuCFerrichrome-specific ABC transporter ATP-binding protein1.491.86ON
CD630_28760 CDIF630erm_03144fhuGFerrichrome-specific ABC transporter permease1.00ON3.85ON
CD630_28770 CDIF630erm_03145fhuBFerrichrome-specific ABC transporter permease1.15ON3.27ON+
CD630_28780 CDIF630erm_03146fhuDFerrichrome-specific ABC transporter, substrate-binding0.782.432.734.47+
CD630_29890 CDIF630erm_03273ssuA2Sulfonate family ABC transporter substrate-binding protein2.602.294.393.73
CD630_29900 CDIF630erm_03274ssuB2Sulfonate family ABC transporter ATP-binding protein2.913.094.504.81
CD630_29910 CDIF630erm_03275ssuC2Sulfonate family ABC transporter permease3.536.10
CD630_29920 CDIF630erm_03276Uncharacterized protein, iron hydrogenase-like2.931.074.385.83
CD630_10870 CDIF630erm_01231zupTZinc transporter ZupT1.85ON6.19ON+
CD630_05910 CDIF630erm_00704ATPase2.416.772.807.54
CD630_05920 CDIF630erm_00705Hypothetical protein2.045.211.935.64+
CD630_29970 CDIF630erm_03281Iron family ABC transporter ATP-binding protein1.020.191.081.16
CD630_29980 CDIF630erm_03282Iron family ABC transporter permease0.420.061.95
CD630_29990 CDIF630erm_03283Iron family ABC transporter substrate-binding protein0.17-0.830.650.48
CD630_14770 CDIF630erm_01641feoAFerrous iron transport protein FeoA1.51ON-1.18ON+
CD630_14780 CDIF630erm_01642feoAFerrous iron transport protein FeoA11.025.70-1.133.69
CD630_14790 CDIF630erm_01643feoB1Ferrous iron transport protein FeoB10.777.19-0.164.78+
CD630_14800 CDIF630erm_01644Hypothetical protein0.40-0.01
CD630_15170 CDIF630erm_01684feoBFerrous iron transport protein FeoB-0.63-0.92
CD630_15180 CDIF630erm_01685feoAFerrous iron transport protein FeoA--0.14
CD630_17451 CDIF630erm_01939feoAFerrous iron transport protein-2.340.36-2.080.98+
CD630_21680 CDIF630erm_02400hcpHydroxylamine reductase-0.810.29-2.21OFF
CD630_21690 CDIF630erm_02401Iron-sulfur binding protein-1.86-3.06
CD630_03240 CDIF630erm_00452cbiMCobalamin transport protein CbiM-2.19ON-2.55
CD630_03250 CDIF630erm_00453cbiNCobalt ABC transporter substrate-binding protein CbiN-1.81-2.81
CD630_03260 CDIF630erm_00454cbiQCobalt ABC transporter permease CbiQ-2.05ON-1.13ON
CD630_03270 CDIF630erm_00455cbiOCobalt ABC transporter ATP-binding protein CbiO-0.47-0.18-1.81-0.10
Pili and flagella formation
CD630_35040 CDIF630erm_03817Type IV prepilin peptidase-0.48-0.33
CD630_35050 CDIF630erm_03818Twitching motility protein PilT-0.91-0.52-1.710.12
CD630_35060 CDIF630erm_03819Hypothetical protein-0.64-2.01
CD630_35070 CDIF630erm_03820Type IV pilin-0.29-2.62
CD630_35080 CDIF630erm_03821Type IV pilin-1.40-1.74
CD630_35090 CDIF630erm_03822Type IV pilus assembly protein-1.01-2.43
CD630_35100 CDIF630erm_03823Membrane protein-1.300.08-1.91-0.21
CD630_35110 CDIF630erm_03824Type IV pilus secretion protein0.79-1.43-2.74OFF
CD630_35120 CDIF630erm_03825Type IV pilus transporter system-0.930.40-2.50-0.02
CD630_35130 CDIF630erm_03826Pilin protein-1.610.21-3.13-0.5203828
CD630_02520 CDIF630erm_00375fliJFlagellar protein FliJ2.37ON2.25ON
CD630_02530 CDIF630erm_00376fliKFlagellar hook-length control protein FliK2.601.152.961.36
CD630_02540 CDIF630erm_00377flgDBasal-body rod modification protein FlgD2.682.41
CD630_02550 CDIF630erm_00378flgEFlagellar hook protein FlgE1.420.432.27-0.18
CD630_02551 CDIF630erm_00379FlbDFlagellar protein FlbD3.261.561.280.91
CD630_02560 CDIF630erm_00380motAFlagellar motor rotation protein MotA2.38-0.732.19-0.39
CD630_02570 CDIF630erm_00381motBFlagellar motor rotation protein MotB1.97-0.162.04-0.79
CD630_02580 CDIF630erm_00382fliLFlagellar basal body-associated protein FliL1.840.532.600.24
CD630_02590 CDIF630erm_00383fliZFlagellar protein FliZ1.05ON2.28ON
CD630_02600 CDIF630erm_00384fliPFlagellar biosynthesis protein FliP1.80OFF3.06-0.14
CD630_02610 CDIF630erm_00385fliQFlagellar biosynthetic protein FliQ1.072.50
CD630_02620 CDIF630erm_00386flhBBifunctional flagellar biosynthesis protein FliR/FlhB2.383.59
CD630_02630 CDIF630erm_00387flhAFlagellar biosynthesis protein FlhA3.840.184.440.10
CD630_02640 CDIF630erm_00388flhFFlagellar biosynthesis regulator FlhF3.611.043.841.30
CD630_02650 CDIF630erm_00389flhGFlagellar biosynthesis protein FlhG1.990.283.570.21
CD630_02660 CDIF630erm_00390fliAFlagellar operon RNA polymerase sigma-28 factor3.54-0.014.15OFF
CD630_02670 CDIF630erm_00391Flagellar protein2.800.653.76OFF
CD630_02671Flagellar protein3.574.06ON
CD630_02680 CDIF630erm_00392flgG1Flagellar basal body rod protein FlgG3.440.742.922.00
CD630_02690 CDIF630erm_00393flgGFlagellar basal body rod protein FlgG3.250.783.47OFF
CD630_02700 CDIF630erm_00394fliMFlagellar motor switch protein FliM2.980.183.41-0.12
CD630_02710 CDIF630erm_00395fliNFlagellar motor switch phosphatase FliN3.330.432.970.04
CD630_02260 CDIF630erm_00348Lytic transglycosylase-3.230.78-3.181.96+
CD630_02270 CDIF630erm_00349Hypothetical protein-1.990.13-3.99-0.01
CD630_02280 CDIF630erm_00350fliNFlagellar motor switch protein FliN-2.250.25-2.840.16
CD630_02290 CDIF630erm_00351flgMNegative regulator of flagellin synthesis-2.081.19-3.40OFF
CD630_02300 CDIF630erm_00352Flagellar biosynthesis protein-2.410.92-3.120.59
CD630_02310 CDIF630erm_00353flgKFlagellar hook-associated protein FlgK-2.081.58-3.510.08
CD630_02320 CDIF630erm_00354flgLFlagellar hook-associated protein FlgL-2.210.22-3.88-0.46
CD630_02330 CDIF630erm_00355fliWFlagellar assembly factor FliW-2.66-0.81-3.160.15
CD630_02340 CDIF630erm_00356crsACarbon storage regulator CsrA-1.870.09-2.57-0.46
CD630_02350 CDIF630erm_00357fliS1Flagellar protein FliS1-1.331.91-3.041.89
CD630_02360 CDIF630erm_00358fliS2Flagellar protein FliS2-1.030.15-2.300.20
CD630_02370 CDIF630erm_00359fliDFlagellar hook-associated protein FliD-0.941.65-2.450.30
CD630_02380 CDIF630erm_00360Hypothetical protein-0.691.30-3.06-0.56
CD630_02390 CDIF630erm_00361fliCFlagellin C-0.090.14-1.57-0.93
CD630_22140 CDIF630erm_02447sinRHTH-type transcriptional regulator1.85OFF2.460.72
CD630_22150 CDIF630erm_02448HTH-type transcriptional regulator2.172.6802449
CD630_19970 CDIF630erm_02215Proline iminopeptidae2.040.264.071.63
CD630_19980 CDIF630erm_02216TetR family transcriptional regulator1.85ON3.73ON

Polyamine biosynthesis and transport

CD630_08880 CDIF630erm_01008speAArginine decarboxylase3.92ON4.48ON+
CD630_08890 CDIF630erm_01009speHS-adenosylmethionine decarboxylase2.57ON2.95ON
CD630_08900 CDIF630erm_01010speEPolyamine aminopropyl transferase4.530.383.780.59
CD630_08910 CDIF630erm_01011speBAgmatinase5.41-0.314.950.53
CD630_10230 CDIF630erm_01159Transcriptional regulator3.64-0.322.210.66
CD630_10240 CDIF630erm_01160potASpermidine/putrescine ABC transporter ATP-binding protein3.43-0.063.050.43
CD630_10250 CDIF630erm_01161potBSpermidine/putrescine ABC transporter permease3.24-0.663.22-0.66
CD630_10260 CDIF630erm_01162potCSpermidine/putrescine ABC transporter permease2.983.23
CD630_10270 CDIF630erm_01163potDSpermidine/putrescine ABC transporter substrate-binding protein2.57-0.582.941.78

Antibiotic/CAMP resistance and cell wall restructuring

CD630_28510 CDIF630erm_03118dltCD-alanine–poly(phosphoribitol) ligase subunit 21.512.10
CD630_28520 CDIF630erm_03119dltBD-alanyl transferase DltB2.84OFF2.79OFF
CD630_28530 CDIF630erm_03120dltAD-alanine–poly(phosphoribitol) ligase subunit 11.37-0.801.68-1.19
CD630_28540 CDIF630erm_03122dltDD-alanine transferase DltD1.490.131.370.01
CD630_16260 CDIF630erm_01803vanGD-alanyl-alanine synthetase A-1.002.91
CD630_16270 CDIF630erm_01804vanYD-alanyl-D-alanine carboxypeptidase-0.893.13
CD630_16280 CDIF630erm_01805vanTGAlanine racemase 10.643.47
CD630_03160 CDIF630erm_00443ABC transporter permease1.102.42
CD630_03170 CDIF630erm_00444ABC transporter permease0.672.61
CD630_03180 CDIF630erm_00445Bacitracin/multidrug family ABC transporter ATP-binding protein1.51-0.192.850.45
CD630_08200 CDIF630erm_00938Two-component response regulator0.72ON1.58ON
CD630_08210 CDIF630erm_00939Two-component sensor histidine kinase1.39ON2.76ON
CD630_08220 CDIF630erm_00940Multidrug family ABC transporter ATP-binding protein1.042.35
CD630_08230 CDIF630erm_00941Multidrug family ABC transporter permease-0.381.62
CD630_08240 CDIF630erm_00943Multidrug family ABC transporter permease0.783.41
CD630_20030 CDIF630erm_02221effDMATE family drug/sodium antiporter-3.56-1.20
CD630_20040 CDIF630erm_02222effRMarR family transcriptional regulator-5.25-0.75-2.983.12
CD630_15570 CDIF630erm_01726Peptidyl-prolyl isomerase1.07-0.583.690.16+
CD630_15580 CDIF630erm_01727csfVECF RNA polymerase sigma factor CsfV2.293.42
CD630_15590 CDIF630erm_01728rsiVAnti ECF RNA polymerase sigma factor RsiV1.552.73
CD630_26510 CDIF630erm_02905murGUDP-N-acetylglucosamine-N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N- acetylglucosamine transferase1.300.631.541.34
CD630_26520 CDIF630erm_02906spoVECell division/stage V sporulation protein0.912.04
CD630_26530 CDIF630erm_02907murDUDP-N-acetylmuramoylalanine–D-glutamate ligase0.770.111.450.42
CD630_26540 CDIF630erm_02908mraYPhospho-N-acetylmuramoyl-pentapeptide-transferase0.822.37
CD630_26550 CDIF630erm_02909murFUDP-N-acetylmuramoyl-tripeptide–D-alanyl-D-alanine ligase2.59-0.262.740.21
CD630_27780 CDIF630erm_03041Glycosyl transferase family protein0.98-0.101.260.10
CD630_27790 CDIF630erm_03042manCMannose-1-phosphate guanylyltransferase1.330.812.470.33
CD630_27800 CDIF630erm_03043pgmPhosphoglucomutase2.750.223.200.06
CD630_27810 CDIF630erm_03044mviNTransmembrane virulence factor3.67-0.934.130.78
CD630_02840 CDIF630erm_00408PTS system mannose/fructose/sorbose transporter subunit IIA-0.040.88
CD630_02850 CDIF630erm_00409PTS system mannose/fructose/sorbose transporter subunit IIB1.860.142.610.62
CD630_02860 CDIF630erm_00410PTS system mannose/fructose/sorbose transporter subunit IIA2.27-0.522.430.64
CD630_02870 CDIF630erm_00411PTS system mannose/fructose/sorbose transporter subunit IIB1.900.202.701.00
CD630_02880 CDIF630erm_00412PTS system mannose/fructose/sorbose transporter subunit IIC1.51-0.142.680.06
CD630_02890 CDIF630erm_00413PTS system mannose/fructose/sorbose transporter subunit IID1.90-0.081.680.46
CD630_32070 CDIF630erm_03501Multi antimicrobial extrusion protein1.302.93
CD630_32080 CDIF630erm_03502MarR family transcriptional regulator0.99ON2.77ON
CD630_35140 CDIF630erm_03828prsRibose-phosphate pyrophosphokinase1.89-0.102.310.30
CD630_35150 CDIF630erm_03829glmUBifunctional N-acetylglucosamine-1- phosphate uridyltransferase/glucosamine-1-phosphate acetyltransferase1.51-0.272.040.40+
CD630_10090 CDIF630erm_01145GntR family transcriptional regulator-3.62-2.36
CD630_10100 CDIF630erm_01146nagAN-acetylglucosamine-6-phosphate deacetylase-2.69-2.60-2.02-0.22
CD630_10110 CDIF630erm_01147nagBGlucosamine-6-phosphate deaminase-2.741.69-1.740.19

Energy metabolism

CD630_32370 CDIF630erm_03533prdFProline racemase3.03-1.484.04-1.14
CD630_32380 CDIF630erm_03534Proline reductase PrdE-like protein4.314.34
CD630_32390 CDIF630erm_03535prdEProline reductase PrdE4.14-2.054.48-2.14
CD630_32400 CDIF630erm_03536prdDProline reductase PrdD4.18-1.834.88-1.00
CD630_32410 CDIF630erm_03537prdBProline reductase1.74-0.532.69-0.80
CD630_32430 CDIF630erm_03539Hypothetical protein2.90-0.792.07-0.39
CD630_32440 CDIF630erm_03540prdAD-proline reductase PrdA2.98-0.673.05-0.83
CD630_32450 CDIF630erm_03541prdRSigma-54 dependent transcriptional regulator0.610.02-1.02-0.80
CD630_32460 CDIF630erm_03542Surface protein-1.35-2.85
CD630_32470 CDIF630erm_03544prdCElectron transfer protein4.62-0.964.78-0.90
CD630_11370 CDIF630erm_01284rnfCElectron transport complex protein RnfC2.64-0.732.91-0.49
CD630_11380 CDIF630erm_01285rnfDElectron transport complex protein RnfD2.01-1.193.58-0.62
CD630_11390 CDIF630erm_01286rnfGElectron transport complex protein RnfG2.670.473.310.41
CD630_11400 CDIF630erm_01287rnfEElectron transport complex protein RnfE1.17OFF3.47OFF
CD630_11410 CDIF630erm_01288rnfAElectron transport complex protein RnfA1.883.55
CD630_11420 CDIF630erm_01289rnfBElectron transport complex protein RnfB1.61-1.382.47-0.91
CD630_11700 CDIF630erm_01318larALactate racemase1.412.86
CD630_11710 CDIF630erm_01319etfBLactate dehydrogenase, electron transfer flavoprotein beta subunit0.67OFF2.43OFF
CD630_11720 CDIF630erm_01320etfALactate dehydrogenase, electron transfer flavoprotein alpha subunit-0.660.63
CD630_11730 CDIF630erm_01321lactate dehydrogenase (electron bifurcating), catalytic subunit-0.30-0.570.73OFF
CD630_03940 CDIF630erm_00522ldhA(R)-2-hydroxyisocaproate dehydrogenase-8.37OFF-8.66OFF
CD630_03950 CDIF630erm_00523hadAIsocaprenoyl-CoA:2-hydroxyisocaproate CoA-transferase-8.33OFF-11.10OFF00519
CD630_03960 CDIF630erm_00524hadI2-hydroxyisocaproyl-CoA dehydratase activator-0.79OFF-11OFF
CD630_03970 CDIF630erm_00525hadBOxygen-sensitive 2-hydroxyisocaproyl-CoA dehydratase subunit B-7.47OFF-10.52OFF
CD630_03980 CDIF630erm_00526hadCOxygen-sensitive 2-hydroxyisocaproyl-CoA dehydratase subunit C-7.81-4.86-10.94OFF
CD630_03990 CDIF630erm_00527acdBAcyl-CoA dehydrogenase-7.43-4.27-10.17-4.76
CD630_04000 CDIF630erm_00528etfB1Electron transfer flavoprotein subunit beta-7.28-3.90-10.48-4.50
CD630_04010 CDIF630erm_00529etfA1Electron transfer flavoprotein subunit alpha-7.50-3.90-10.39-4.98
CD630_10540 CDIF630erm_01194bcd2Butyryl-CoA dehydrogenase-5.89OFF-8.00OFF
CD630_10550 CDIF630erm_01195etfBElectron transfer flavoprotein subunit beta-7.47OFF-7.70OFF
CD630_10560 CDIF630erm_01196etfAElectron transfer flavoprotein subunit alpha-6.75OFF-7.75OFF
CD630_10570 CDIF630erm_01197crt23-hydroxybutyryl-CoA dehydratase-6.37-7.48OFF
CD630_10580 CDIF630erm_01198hbd3-hydroxybutyryl-CoA dehydrogenase-5.21OFF-5.97OFF
CD630_10590 CDIF630erm_01199thlA1Acetyl-CoA acetyltransferase-6.22OFF-6.43OFF
CD630_29660 CDIF630erm_03250adhEBifunctional acetaldehyde-CoA/alcohol dehydrogenase-8.19-4.52-9.86-5.91
CD630_23380 CDIF630erm_025774hbD4-hydroxybutyrate dehydrogenase-1.00-0.87-1.23-1.0602575
CD630_23390 CDIF630erm_02578cat24-hydroxybutyrate CoA-transferase-0.87OFF-0.50OFF
CD630_23400 CDIF630erm_02579Hypothetical protein-2.16-1.55
CD630_23410 CDIF630erm_02580abfDGamma-aminobutyrate metabolism dehydratase/isomerase-1.41-1.74-1.23-1.16
CD630_23420 CDIF630erm_02581sucDSuccinate-semialdehyde dehydrogenase-2.47-3.77
CD630_23430 CDIF630erm_02582cat1Succinyl-CoA:coenzyme A transferase-3.35-3.58
CD630_23440 CDIF630erm_02583Membrane protein-4.79-5.28
CD630_23480 CDIF630erm_02587grdDGlycine reductase complex component DOFFOFF
CD630_23490 CDIF630erm_02588grdCGlycine reductase complex component C-3.70-3.70
CD630_23510 CDIF630erm_02589grdBGlycine reductase complex component BOFFOFF
CD630_23520 CDIF630erm_02592grdAGlycine reductase complex component A--
CD630_23540 CDIF630erm_02594grdEGlycine reductase complex component E-5.02-2.84-5.22OFF
CD630_23550 CDIF630erm_02595trxA2Thioredoxin 2-3.66-3.66+
CD630_23560 CDIF630erm_02596trxB3Thioredoxin reductase-OFF
CD630_23570 CDIF630erm_02597grdDXOFF
CD630_08530 CDIF630erm_00972oppBOligopeptide family ABC transporter permease-2.81OFF-2.26OFF
CD630_08540 CDIF630erm_00973oppCOligopeptide family ABC transporter permease-2.67-2.28
CD630_08550 CDIF630erm_00974oppAOligopeptide family ABC transporter substrate-binding protein-2.48-0.37-3.22-1.02
CD630_08560 CDIF630erm_00975oppDABC transporter ATP-binding protein-2.38-3.65
CD630_15360 CDIF630erm_01704nfnANADH-dependent reduced ferredoxin:NADP oxidoreductase-2.56-1.18-2.43-0.71
CD630_15370 CDIF630erm_01705nfnBNADH-dependent reduced ferredoxin:NADP oxidoreductase-2.69-1.77-3.01-1.53
CD630_08820 CDIF630erm_01002glgCGlucose-1-phosphate adenylyltransferase-1.89-3.38
CD630_08830 CDIF630erm_01003glgDGlycogen biosynthesis protein-1.70-2.42-4.22OFF
CD630_08840 CDIF630erm_01004glgAGlycogen synthase-2.451.98-3.24-0.37
CD630_08850 CDIF630erm_01005glgPGlycogen phosphorylase-1.620.49-3.380.14
CD630_08860 CDIF630erm_01006amyBAmylopullulanase-0.12-0.29-2.680.05
CD630_23180 CDIF630erm_02556Phosphohexomutase2.010.581.560.21
CD630_23190 CDIF630erm_02557rpeRibulose-phosphate 3-epimerase1.24ON1.19ON
CD630_23200 CDIF630erm_02558rpiB1Ribose-5-phosphate isomerase B3.190.002.23-0.02
CD630_23210 CDIF630erm_02559Transketolase1.750.442.010.22
CD630_23220 CDIF630erm_02560tktTransketolase1.480.232.630.29
CD630_11200 CDIF630erm_01264pflDFormate acetyltransferase-0.51-0.122.031.70
CD630_11210 CDIF630erm_01265pflCPyruvate formate-lyase activating enzyme-0.322.21
CD630_11220 CDIF630erm_01266Transcriptional regulator-1.51-0.631.480.05
CD630_32820 CDIF630erm_03582pflDPyruvate formate-lyase-1.38-2.38-2.88-2.94
CD630_32830 CDIF630erm_03583pflEPyruvate formate-lyase-2.11-3.53
CD630_33130 CDIF630erm_03614hydN1Oxidoreductase Fe-S subunit-2.44-3.60
CD630_33140 CDIF630erm_03615hydAIron hydrogenase-2.59OFF-3.08-1.30
CD630_33150 CDIF630erm_03616hydN2Oxidoreductase Fe-S subunit-3.54-1.13-3.00-0.86+
CD630_33151 CDIF630erm_03617Hypothetical protein-1.53-3.00
CD630_33160 CDIF630erm_03618fdhDFormate dehydrogenase accessory protein FdhD-2.22-3.03
CD630_33170 CDIF630erm_03619fdhFFormate dehydrogenase-H-2.88-1.63-3.37-1.72
CD630_01740 CDIF630erm_00296cooSCarbon monoxide dehydrogenase-3.57-1.46-4.70-2.05
CD630_01750 CDIF630erm_00297cooFOxidoreductase Fe-S subunit-2.43-4.33
CD630_01760 CDIF630erm_00298Oxidoreductase NAD/FAD binding subunit-2.12OFF-3.96OFF
CD630_12780 CDIF630erm_01431iscRRrf2 family transcriptional regulator4.433.30-0.271.44
CD630_12790 CDIF630erm_01432iscS2Cysteine desulfurase0.552.69-3.250.03
CD630_12800 CDIF630erm_01433NifU family iron-sulfur cluster assembly protein0.833.83-2.970.31
CD630_34670 CDIF630erm_03778atpCATP synthase subunit epsilon3.830.561.371.04
CD630_34680 CDIF630erm_03779atpDATP synthase subunit beta2.250.602.040.94
CD630_34690 CDIF630erm_03780atpGATP synthase subunit gamma3.910.512.830.55
CD630_34700 CDIF630erm_03781atpAATPase subunit alpha3.720.612.441.00
CD630_34710 CDIF630erm_03782atpHATP synthase subunit delta3.650.492.670.72
CD630_34720 CDIF630erm_03783atpFATP synthase subunit B3.330.162.310.47
CD630_34730 CDIF630erm_03784atpEATP synthase subunit C2.81ON1.58ON
CD630_34740 CDIF630erm_03785atpBATP synthase subunit A1.591.770.94
CD630_29540 CDIF630erm_03237atpDV-type ATP synthase subunit D-1.47-2.46
CD630_29550 CDIF630erm_03238atpBV-type ATP synthase subunit B-3.00-0.98-2.58-1.34
CD630_29560 CDIF630erm_03239atpAV-type ATP synthase subunit A-2.35-0.73-2.54-0.95+
CD630_29561 CDIF630erm_03240atpFV-type ATP synthase subunit F-2.40-1.52
CD630_29570 CDIF630erm_03241atpCV-type ATP synthase subunit C-2.32-2.56
CD630_29580 CDIF630erm_03242atpEV-type ATP synthase subunit E-1.47OFF-2.92OFF
CD630_29590 CDIF630erm_03243atpKV-type ATP synthase subunit K-1.47-2.10-2.48-1.20
CD630_29600 CDIF630erm_03244atpIV-type ATP synthase subunit I-2.73OFF-3.24OFF
CD630_29610 CDIF630erm_03245Hypothetical protein-1.780.00-2.92-0.80

Flavodoxin formation

CD630_19990 CDIF630erm_02217fldxFlavodoxin4.54ON4.54ON
CD630_16970 CDIF630erm_01882ribH6.7-dimethyl-8-ribityllumazine synthase2.820.313.860.68+
CD630_16980 CDIF630erm_01883ribBARiboflavin biosynthesis bifunctional 3.4-dihydroxy-2-butanone 4-phosphate synthase/GTP cyclohydrolase2.100.402.620.99
CD630_16990 CDIF630erm_01884ribERiboflavin synthase subunit alpha1.820.261.55-0.07
CD630_17000 CDIF630erm_01885ribDRiboflavin biosynthesis bifunctional diaminohydroxyphosphoribosylamino pyrimidine deaminase/5-amino-6-(5-phosphoribosylamino)uracil reductase1.390.351.811.02
CD630_23310 CDIF630erm_02570mtlDMannitol-1-phosphate 5-dehydrogenase-6.28-2.60-5.79-1.91
CD630_23320 CDIF630erm_02571mtlFPTS system mannitol-specific transporter subunit IIA-5.98OFF-5.53-1.54
CD630_23330 CDIF630erm_02572mtlRPTS operon transcription antiterminator-5.78OFF-6.17OFF
CD630_23340 CDIF630erm_02573mtlAPTS system mannitol-specific transporter subunit IICB-6.29OFF-5.92-3.14

Fatty acid metabolism

CD630_11770 CDIF630erm_01326fapRFatty acid biosynthesis transcriptional regulator2.530.173.160.11
CD630_11780 CDIF630erm_01327plsXPhosphate acyltransferase1.93-1.293.25-0.22
CD630_11790 CDIF630erm_01328fabH3-oxoacyl-ACP synthase2.120.094.000.92
CD630_11800 CDIF630erm_01329fabKEnoyl-(acyl-carrier-protein) reductase II2.86-0.163.610.50
CD630_11810 CDIF630erm_01330fabDMalonyl CoA-acyl carrier protein transacylase3.03-0.183.870.41
CD630_11820 CDIF630erm_01331fabG3-oxoacyl-ACP reductase3.65-0.063.940.23
CD630_11830 CDIF630erm_01332acpPAcyl carrier protein2.954.28
CD630_11840 CDIF630erm_01333fabF3-oxoacyl-ACP synthase2.980.074.710.6901334

CRISPR/Cas and prophages

CD630_29750 CDIF630erm_03259CRISPR-associated endoribonuclease Cas2-0.74-2.13
CD630_29760 CDIF630erm_03260CRISPR-associated endonuclease Cas1-0.87-1.67
CD630_29770 CDIF630erm_03261CRISPR-associated Cas4 family protein-0.41-2.72
CD630_29780 CDIF630erm_03262CRISPR-associated Cas3 family helicase-0.26-2.20
CD630_29790 CDIF630erm_03263CRISPR-associated Cas5 family protein-1.30-1.66
CD630_29800 CDIF630erm_03264CRISPR-associated autoregulatorDevR family protein0.20-0.55-1.97-1.28
CD630_29810 CDIF630erm_03265CRISPR-associated protein-1.27-1.20-1.78OFF
CD630_29820 CDIF630erm_03266CRISPR-associated Cas6 family protein-0.60-2.92
CD630_13650 CDIF630erm_01522XkdN-like protein--2.30+
CD630_13660 CDIF630erm_01524Tail protein-1.33ON-3.28
CD630_13680 CDIF630erm_01526Cell wall XkdQ-like hydrolase0.02-3.93
CD630_13700 CDIF630erm_01528XkdS-like protein--1.07
CD630_13710 CDIF630erm_01529Baseplate assembly protein-1.33-2.06
CD630_13720 CDIF630erm_01530XkdT-like protein-1.27-2.90
CD630_13740 CDIF630erm_01532Beta-lactamase-inhibitor protein II0.64ON-1.58

DNA/RNA nucleotide metabolism

CD630_02180 CDIF630erm_00340purE5-carboxyaminoimidazole ribonucleotide mutase0.09-0.242.120.80
CD630_02190 CDIF630erm_00341purCPhosphoribosylaminoimidazolesuccino carboxamide synthase-0.22-0.212.590.41
CD630_02200 CDIF630erm_00342purFAmidophosphoribosyltransferase1.65-0.692.960.09
CD630_02210 CDIF630erm_00343purGPhosphoribosylformylglycinamidinecyclo-ligase0.60-0.762.94-0.69
CD630_02220 CDIF630erm_00344purNPhosphoribosylglycinamideformyl transferase2.66-0.413.49-0.04
CD630_02230 CDIF630erm_00345purHBifunctional phosphoribosylaminoimidazole carboxamideformyltransferase/IMP cyclohydrolase2.49-0.083.370.24
CD630_02240 CDIF630erm_00346purDPhosphoribosylamine–glycine ligase2.19-0.283.070.32
CD630_02250 CDIF630erm_00347purLPhosphoribosylformylglycinamidine synthase1.24-0.062.230.1900348
CD630_01840 CDIF630erm_00305pyrBAspartate carbamoyltransferase0.190.471.010.60
CD630_01850 CDIF630erm_00306pyrKDihydroorotate dehydrogenase electron transfer subunit2.940.822.820.74
CD630_01860 CDIF630erm_00307pyrDDihydroorotate dehydrogenase 1B1.960.212.720.16
CD630_01870 CDIF630erm_00308pyrEOrotatephosphoribosyltransferase3.920.193.380.54
CD630_25940 CDIF630erm_02848uraAUracil-specific ABC transporter permease0.960.173.83-0.46
CD630_25950 CDIF630erm_02849pyrRBifunctional pyrimidine operon regulatory protein/uracil phosphoribosyltransferase0.052.170.62+
CD630_25960 CDIF630erm_02850Pseudouridylate synthase1.852.05
CD630_25970 CDIF630erm_02851lspALipoprotein signal peptidase2.473.02
CD630_27690 CDIF630erm_03032Polysaccharide biosynthesis protein1.950.292.73-0.39
CD630_27700 CDIF630erm_03033Group 1 glycosyl transferase1.22-0.322.550.20
CD630_27710 CDIF630erm_03034rkpKUDP-glucose 6-dehydrogenase2.13-0.052.590.41
CD630_27720 CDIF630erm_03035tuaGFamily 2 glycosyl transferase2.23-0.233.250.35
CD630_27730 CDIF630erm_03036Family 2 glycosyl transferase2.45-0.532.590.06
CD630_27740 CDIF630erm_03037Family 2 glycosyl transferase1.24-0.522.300.64
CD630_27750 CDIF630erm_03038Glycerophosphotransferase2.64-0.612.73-0.07
CD630_27760 CDIF630erm_03039Family 2 glycosyl transferase0.78-0.061.990.17

Integration of the transcriptome (RNA-Seq), proteome, metabolome and bioinformatics-based Fnr –binding site analyses for the analysis of C. difficile to low iron conditions.

T, transcriptome, P, proteome, FC, fold change, shown are corresponding locus tags of C. difficile 630 [according to (Monot et al., 2011)] and 630Δerm [according to (Dannheim et al., 2017a)]. The gene number in the Fur column identifies a gene close to the regulated genes shown in the table possessing a potential Fur box in its upstream region. ON and OFF describe proteomics result, where under one of the two compared conditions/strains no protein was detected. If the first protein is detectable under conditions of interest, it is ON, if it is absent, it is OFF.

Proteomics

Bacteria were grown as outlined for the RNA-seq experiments. Cell pellets were suspended in 700 μl of ice-cold urea-containing buffer (7 M urea, 2 M thiourea, 50 mM dithiothreitol (DTT), 4% (w/v) 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS), 50 mM Tris-HCl). Cell lysis was performed by sonication (probe MS73, Sonoplus, Bandelin, Berlin, Germany) in six cycles of 60s (amplitude 60%, 0.1 s pulse every 0.5 s) on ice. Cell debris was removed by centrifugation at 6,000 g for 10 min at 4°C. Proteins of cell free resulting lysates were precipitated by addition of ice-cold acetone [in a 1:5 ratio (v/v)] for 20 h at -20°C. Subsequently, samples were allowed to warm to room temperature and were centrifuged at 22,000 g for 45 min at room temperature. The supernatant was discarded, the protein pellets were washed in 80% acetone, and subsequently in 100% acetone, before they were air-dried. The protein pellets were solubilized in SDS-containing urea-buffer [7 M urea, 2 M thiourea, 1% (v/v) SDS]. For protein concentration determination, 10 μl of each sample was separated by SDS-PAGE (Criterion TGX Precast Gels 4–20%, Bio-Rad, Hercules, CA, United States). Resulting SDS-gels were fixed for 1 h in 40% (v/v) EtOH, 10% (v/v) glacial acidic acid, washed in H2O and stained by the Flamingo fluorescent dye (Bio-Rad, Hercules, CA, United States) for 1 h. Resulting fluorescence signals of the samples were measured by a Typhoon TRIO scanner (GE Healthcare, Little Chalfont, United Kingdom), quantified by ImageQuant 5.2 (GE Healthcare, Little Chalfont, United Kingdom) and used for quantitative normalization of protein. Comparable protein amounts (∼30 μg of protein per sample) for each analyzed condition were separated by SDS-PAGE as described above and stained overnight with Colloidal Coomassie. Gel lanes were cut into 10 slices and proteins subjected to in-gel trypsinization as described previously (Lassek et al., 2015).

The eluted peptides were subjected to LC-MS/MS analyses performed on a Proxeon nLC 1000 coupled online to an Orbitrap Elite mass spectrometer (Thermo Fisher Scientific, Waltham, MA, United States). In-house self-packed columns [i.d. 100 μm, o.d. 360 μm, length 150 mm; packed with 1.7 μm Aeris XB-C18 reversed-phase material (Phenomenex, Aschaffenburg, Germany)] were loaded and washed with 10 μl of buffer A [0.1% (v/v) acetic acid] at a maximum pressure of 750 bar. For coupled LC-MS/MS analysis, elution of peptides took place with a non-linear 80 min gradient from 1 to 99% buffer B [0.1% (v/v) acetic acid in acetonitrile] at a constant flow rate of 300 nl/min. Eluting peptides were recorded in the mass spectrometer at a resolution of R = 60,000 with lockmass correction activated. After acquisition of the full MS spectra, up to 20 dependent scans (MS/MS) were performed according to precursor intensity by collision-induced dissociation fragmentation (CID) in the linear ion trap. For protein identification and quantification from raw MS data, the Proteome DiscovererTM software (version 1.4, Thermo Fisher Scientific Inc., Waltham, MA, United States) was used, and results further evaluated employing Scaffold (version 4.4, Proteome Software Inc., Portland, OR, United States) as previously described in detail (Lassek et al., 2015). In brief, Sequest HT database searches were performed with raw files against a C. difficile 630 protein database containing common contaminations (3804 entries). The following search parameters were used: enzyme type = trypsin (KR), peptide tolerance = 10 ppm, tolerance for fragment ions = 0.6 Da, b- and y-ion series, variable modification = methionine (15.99 Da); a maximum of three modifications per peptide was allowed. Peptide and protein identifications were accepted with a false discovery rate (FDR) of at most 1%, requiring a minimum of at least two unique peptides for protein identification and quantification. Moreover, only proteins that were at least identified in two out of three biological replicates were taken into account. Relative protein quantification was achieved by calculating the normalized area under the curve (NAUC). Identification of statistical differences in relative protein amounts was performed using t-test (p-value < 0.05) including adjusted Bonferroni correction and all possible permutations. Proteome data are summarized in Supplementary Table S4. Data of interest can be easily converted into the C. difficile 630Δerm annotation using conversion Supplementary Table S5. All MS raw data as well as Proteome Discoverer and Scaffold result files have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository (Vizcaino et al., 2016) with data set identifier PXD011161.

Metabolomics

Cells were grown to the mid-exponential growth phase and harvested anaerobically as indicated above for the transcriptome and proteome experiments. The supernatant was removed and the cells were immediately quenched by suspension in pre-cooled isotonic sodium chloride-methanol [50% (v/v), -32°C]. Cells were pelleted at -20°C, 8,000 g for 5 min. The quenching solution was removed and the cells were frozen in liquid nitrogen. Cell lysis and metabolite extraction were performed as described previously (Zech et al., 2009; Dannheim et al., 2017b). One ml of the polar phase was dried in a vacuum concentrator and stored at -80°C prior to analysis. Extracellular samples were prepared as described previously (Neumann-Schaal et al., 2015). Volatile and non-volatile compounds in the culture supernatants and cell free extracts were analyzed via GC/MS as described earlier (Neumann-Schaal et al., 2015). Raw data obtained from GC/MS measurements were processed by applying version 2.2N-2013-01-15 of the in-house developed software MetaboliteDetector (Hiller et al., 2009). The peak identification was performed in a non-targeted manner with a combined compound library. After processing, non-biological peaks and artifacts were eliminated with the aid of blanks. Peak areas were normalized to the corresponding internal standards (o-cresol or ribitol) and derivatives were summarized. Significant changes in metabolite levels were calculated by non-parametric Wilcoxon–Mann–Whitney test (Mann and Whitney, 1947) using Benjamini–Hochberg correction (Benjamini and Hochberg, 1995) to control the false discovery rate. Metabolome data are summarized in Supplementary Table S6.

HPLC/MS-Based Analysis of Coenzyme A-Derivatives

Coenzyme A (CoA)-esters were isolated by cell breakage using a Precellys 24 homogenizer (Peqlab, Erlangen, Germany) at -10°C. The procedure included three cycles of homogenization (6,800 rpm, 30 s with equivalent breaks). The lysate was transferred to 10 ml of ice-cold ammonium acetate (25 mM, pH 6) and centrifuged (5 min at 10,000 g, 4°C). CoA-derivatives were extracted on a Strata XL-AW solid phase extraction column (Phenomenex, Aschaffenburg, Germany) as described previously (Wolf et al., 2016). CoA-derivatives were analyzed on a Dionex ultimate 3000 system (Thermo Scientific Inc., Darmstadt, Germany) coupled to a Bruker MicroTOF QII mass spectrometer (Bruker Daltonik GmbH, Karlsruhe, Germany) equipped with an electrospray ionization interface. The separation and detection was performed as described previously (Peyraud et al., 2009; Wolf et al., 2016). Raw data were processed using the XCMS package (Smith et al., 2006; Benton et al., 2008; Tautenhahn et al., 2008) for R (version 3.0.3) as described previously (Wolf et al., 2016). Significant changes in metabolite levels were calculated by non-parametric Wilcoxon-Mann-Whitney test (Mann and Whitney, 1947) using Benjamini–Hochberg correction (Benjamini and Hochberg, 1995) to control the false discovery rate. Metabolome data are summarized in the Supplementary Table S6.

Bioinformatics

De novo Motif Search

Motif search was performed with the standalone version of MEME (Bailey et al., 2009) on the promoter sequences [-250,0] of 66 genes known to be differentially regulated by Fur and involved in the iron metabolism. MEME was run with option “-anr” and without any restrictions on the motif width. Motif presence was confirmed in 11 out of the 66 promoters.

Genome-Wide Motif Scan

We performed genome-wide motif search in the promoters [-250,0] of C. difficile using the de novo obtained position weight matrix (PWM). The standalone version of the MAST tool available in the MEME package was run with option “-norc” (search only the forward strand) once with default other parameters and once with maximal motif hit P-value of 5.10(-5).

Results

Construction of a C. difficile fur Mutant and Definition of High and Low Iron Growth Conditions

The overarching aim of this study was identification and characterization of the Fur regulon at the transcriptional, translational, metabolomics and the phenotypic level. For this purpose a fur mutant was constructed using the ClosTron technology (Heap et al., 2007, 2009, 2010). The fur gene was identified and characterized before by Ho and Ellermeier (2015) and partially by Dubois et al. (2016). Similar to their approaches, a stabile insertional mutation in open reading frame CDIF630_01441 of the laboratory strain C. difficile 630Δerm (Hussain et al., 2005) was generated. The ClosTron system uses a group II intron to insert an erythromycin resistance cassette into the target gene. C. difficile 630Δerm, an erythromycin-sensitive derivative of C. difficile strain 630, was used as the parental strain and is further referred to as wild type. The insertional mutant was confirmed by PCR analysis (Supplementary Figure S1). The growth behavior of the wild type and the constructed fur mutant in logarithmic growth phase was almost identical when tested in the complex Brain-Heart-Infusion (BHI) medium independent of the addition of iron (Supplementary Figure S2). However, the stationary phase was entered earlier by the fur mutant. Similar observations have been made for the fur mutant grown in complex TY medium before (Ho and Ellermeier, 2015). A different growth behavior was observed in Clostridium Minimal Medium (CDMM). Here we tested high (15 mM) and low (0.2 mM) concentrations of iron, in this case iron sulfate. For this purpose a commercial analytical laboratory (Currenta Analytik, Leverkusen, Germany) investigated the CDMM used throughout this investigation with Inductively-Coupled-Plasma Mass Spectrometry (ICP-MS) for its iron content. Highly reproducible, 0.2 mM iron were determined for the medium and used as low iron conditions. For defining high iron conditions CDMM was titrated with increasing amounts of iron and C. difficile wild type growth stimulation was determined. When the point of no further growth stimulation was reached 9.2 mM iron were measured by ICP-MS in CDMM.

We explicitly circumvented the utilization of the chelator 2,2′-dipyridyl (DPP) to achieve low/no iron conditions. Cernat and Scott failed after DPP treatment of C. difficile to recover the bacterial growth by the addition of alternative iron sources including lactoferrin, transferrin, hemoprotein, and heme (Cernat and Scott, 2012). A high-throughput small molecule screen identified DPP as one of the most potent inhibitors of C. difficile growth, even in a mouse model (Katzianer et al., 2014). Latter indicated the importance of iron for C. difficile growth, but also showed the detrimental effects of DPP treatment. Nevertheless, DPP remains an useful and often used tool to achieve complete iron depletion. To our understanding C. difficile does not encounter completely iron free conditions in its environment, thus, we compared high (15 μM) and low (0.2 μM) iron conditions in all experiments of this study. When growth of the wild type and the fur mutant was compared under both iron concentrations, both strains revealed significant reduced growth under iron limited conditions (Figure 1). Complementation of the fur mutant with a plasmid encoded fur restored growth to almost wild type conditions (Supplementary Figure S3). Furthermore, the fur mutant grew much slower and to lower terminal densities compared to the wild type strain. Obviously, Fur is required for optimal growth under high and low iron conditions (Figure 1).

FIGURE 1

Next, different iron sources were analyzed for the ability to restore iron limited growth of the wild type and the fur mutant (Supplementary Figure S4). Addition of 15 mM iron citrate or iron (II) chloride induced a growth behavior of C. difficile similar to that observed for the addition of iron sulfate (compare Figure 1 and Supplementary Figures S4A,B,D). Addition of 10 μM hemin, or 10 μg/ml transferrin did not significantly improve wild type growth, but slightly enhanced the growth of the fur mutant. Substitution with 10 μg/ml ferritin clearly improved the growth of both strains (compare Figure 1 and Supplementary Figures 4C,E,F). Overall, the basic difference in the growth behaviors of the wild type and the mutant strain remained similar under various tested iron conditions, i.e., the various iron sources did not compensate for the loss of Fur in the mutant strain. Obviously, additional functions besides iron regulation are executed by Fur in C. difficile.

Transcriptome, Proteome and Metabolome of Wild Type and the fur Mutant of C. difficile Grown at Iron-Limiting and Iron-Saturated Conditions

We aimed at a multi-level, holistic view on iron-regulation in C. difficile and the contribution of Fur to these processes. To analyze environmental iron conditions close to the gut habitat, we refrained from DPP treatment of the cultures, rather we compared samples taken from low, iron limiting growth conditions (0.2 μM) with samples of iron saturated (15 μM) growth conditions. The transcriptome (RNA-Seq), cytoplasmic proteome, metabolome, and exo-metabolome of wild type and the fur mutant grown under both conditions were compared. Samples were taken in the exponential growth phase as indicated by arrows in Figure 1. This approach enabled us to functionally identify iron regulated processes at the transcriptional and proteomic level, and to observe their metabolic consequences. Furthermore, the inhibitory and promoting activities of Fur became visible. Certain phenotypes were further investigated using electron microscopy and growth experiments.

The RNA-Seq approach identified 3,156 individual transcripts. First, we compared the 4 different transcriptomes (wild type low/high iron, fur mutant low/high iron) by principal component analyses (Supplementary Figure S5). Interestingly, biological triplicates from wild type/low iron, fur/low iron, and fur/high iron showed a certain degree of overlap, while triplicates for wild type/high iron clustered very distinct. As Fur usually acts as a transcriptional repressor at high iron concentration, global transcriptional changes due to high iron availability were mostly effected by the presence of active Fur. The terms “induced” and “repressed” were used for enriched or depleted RNAs throughout the paper. We are fully aware of the fact that comparative RNA-Seq shows changes in RNA abundancies, which might not always correlate with changes in gene expression. Using a log2 fold change of 1 in transcript abundance (p-value of 0.05) as cutoff, 243 genes were found up- and 303 genes down-regulated in response to iron limitation (Supplementary Tables S1S3). Comparing wild type and the fur mutant at high iron 369 genes were found up- and 268 genes found down-regulated (Table 1). In order to visualize the differences of the currently available transcriptome wild type (Ho and Ellermeier, 2015; Hastie et al., 2018) the principal component analysis was employed for all available transcriptome data of C. difficile wild type versus fur mutant at high iron growth conditions. Results are summarized in Supplementary Tables S1S3. We were aware of the fact that highly different transcriptome methods (RNA-Seq versus DNA array) and different low/no iron condition (with and without DPP) were compared. Clear cut differences became visible (Figure 2). The DNA array data of the wild type obtained in the presence of high iron and low/no iron (Hastie et al., 2018) cluster together, nevertheless, with some distance. The DNA array data for the fur mutant obtained at high iron conditions (Ho and Ellermeier, 2015) cluster separate from the RNA-Seq data, however, with the wild type data oriented toward the RNA-Seq wild type data and the fur mutant data toward the RNA-Seq fur mutant data (Figure 2).

FIGURE 2

Analyzing iron limitation in C. difficile with a proteomics approach, a total of 1,639 proteins were identified. A recent investigation of 8 C. difficile proteome yielded 662 quantifiable common proteins (Dresler et al., 2017). Using a cutoff at a log2 fold of 1 (p-value of 0.05) 85 proteins were found down- and 61 up-regulated in response to iron limitation. A total of 170 proteins were not found (OFF) and 85 solely found (ON) under iron limiting conditions (Supplementary Table S5). For the wild type versus fur mutant comparison 1,682 proteins were analyzed. Using the same cutoff 86 proteins were found depleted and 122 enriched in the fur mutant compared to wild type, both grown at high iron conditions. A total of 152 proteins were not detected (OFF) and 128 proteins solely identified (ON) in the fur mutant (Supplementary Table S4). Comparing transcriptome and proteome data, interesting differences were observed, most likely reflecting the delay of the response of the proteome compared to the transcriptome at the analyzed time point (Table 1). These differences will be described and discussed in the context of the various regulated processes below. Furthermore, a significant degree of similarity was observed for the Omics data for high versus low iron and the wild type versus fur mutant at high iron conditions, indicating that major adaptations were controlled directly or indirectly by Fur (Supplementary Table S4).

Combined GC/MS- and LC/MS-based metabolome approaches were employed for the analyses of intracellular metabolites including CoA-esters and for the elucidation of the metabolic composition of the growth medium and corresponding volatiles. Overall, we identified 113 intracellular metabolites including 23 coenzyme A-esters. Extracellularly, 45 metabolites were identified. Using a fold change cutoff of 1.5 and at an adjusted p-value of 0.05, 52 metabolites were found in higher concentration and 13 in lower concentration under low iron conditions (Supplementary Table S5). For the wild type versus fur mutant comparison using the same cutoff 29 metabolites were found more and 31 less abundant in the fur mutant compared to wild type when both were grown at high iron conditions. Overall, the most abundant identified metabolites were dominated by amino acids and their products (5-aminovalerate, glutamate, valine, isoglutamate, leucine, lysine, alanine and more) followed by diverse coenzyme A-esters, cofactors and polyamines (spermine, spermidine). As typically observed for C. difficile, only a few sugars and activated sugars (glucose, glucose-6-phosphate and fructose-1,6-bisphosphate) or intermediates of the central carbon metabolism (2-oxoglutarate) were under the highly abundant metabolites (Supplementary Table S6).

Finally, a bioinformatics approach for the definition of the Fur regulon was taken. Fur binding sites upstream of Fur-regulated genes in C. difficile were combined to define a position weight matric using the MEME motif search tool version 4.11.2. A consensus binding site of TGATAATVAWHWTCA was deduced (Figure 2). Overall, 161 potential strand-specific Fur binding sites were identified up to 250 bp upstream of 147 coding genes/operons. Approximately 20 of these binding sites were found upstream of genes involved in the regulation of the major adaptations processes to low iron condition in C. difficile (Supplementary Table S7).

Fur-Mediated Iron Regulation of Metal Uptake Systems

As expected various iron and other metal uptake systems encoded by fpi, fhu, zupT and the sulfonate transporters encoded by the ssu operon (CDIF630erm_03273–03276) were found more abundant by low iron conditions at the transcriptome and proteome level (Table 1). This response was indirectly mediated by Fur, since a conserved Fur binding site was not detected upstream of the ssu operon. This is in agreement with previously published transcriptome analyses induced (Ho and Ellermeier, 2015; Hastie et al., 2018). In the previous two transcriptome analyses using DPP-treated bacteria as iron depleted condition, the ferrous iron uptake transporter genes feoA1 (CDIF630erm_01641 – 01642) were also found clearly induced (Ho and Ellermeier, 2015; Hastie et al., 2018). Moreover, low induction by iron depletion was observed for feoA5/feoB3 (CDIF630erm_03573 – 03574) and feoA4 (CDIF630erm_01939). None of the FeoA type systems were found more abundant at the transcriptome level in our approach with 0.2 μM iron as low iron conditions. However, the proteome data revealed that FeoAB system encoded by CDIF630erm_01641 – 01643 was induced at low iron condition in a Fur-dependent manner (Table 1). Moreover, the significant differences in the observed fold changes in gene induction between DPP-treated cells (up to 730-fold with the DNA array, over 100-fold for the RNA-seq) and 0.2 μM iron grown cells (around 5-fold) might further explain some of these observations. Possibly, at an iron concentration of 0.2 μM the necessary threshold of iron depletion for the Feo-type systems was not reached. Alternatively, feo gene regulation by low iron with Fur was of transient nature and finished at the time point of sampling. Possibly, the adaptation at this certain time-point was only visible at the proteome level (summarized in Figure 3). Many of the operons/genes (CDIF630erm_01824, CDIF630erm_01827, CDIF630erm_03145, CDIF630erm_03146, CDIF630erm_01641, CDIF630erm_01643, CDIF630erm_01939) involved in iron uptake contain potential Fur binding sites in their upstream region, indicating direct Fur control. Nevertheless, similar results were obtained for the currently available three transcriptome analyses (Ho and Ellermeier, 2015; Hastie et al., 2018). Overall, this response was clearly coordinated directly by Fur, indicated by the multiple potential binding sites (Supplementary Table S7). Some of them were already confirmed by DNA binding studies before (Ho and Ellermeier, 2015).

FIGURE 3

With standard Western diet the iron concentrations in the gut is about 100 mg Fe/g wet weight feces (Pizarro et al., 1987; Lund et al., 1999). However, due to the rising pH in the duodenum and the small intestine solubility of ferric iron decreases and favors the oxidation to ferrous iron in the presence of oxygen. Furthermore, ascorbic acid and citric acid chelate iron and make it available to the microbiome and host. On the other side polyphenols like tannins and catechols from tea or coffee as well phytate from cereals tightly bind iron. Consequently, the amount of iron in the colon lumen that is readily available to bacteria is difficult to estimate (Kortman et al., 2014). The large amounts of different siderophores found in the feces indicate strongly limited access to ferric iron for the gut microbiome (Kortman et al., 2014). In summary, there is always some iron around in the gut. However, the actual iron concentrations might vary with respect to nutrition. Consequently, high and low affinity iron uptake systems are advised. Most likely the differences observed between the proteome and transcriptome data regarding induction of iron-uptake systems of this study as well as the difference to the two transcriptome analyses performed before might be caused by a time-resolved response to iron limitation.

Certain systems found still enhanced at both the RNA and protein level (yclP, ssuA2, ssuB2, CDIF630erm_01231), while other were already formed and the increased abundance became only visible at the protein level (feoA, CDIF630erm_01642; feoB1 CDIF630erm_01643). A co-regulation of the sulfur (ssu operon) and iron metabolism becomes obvious and was observed before (Dubois et al., 2016). This might be explained by the often sulfur-mediated iron coordination in enzymes of C. difficile (see Supplementary Table S8). One of the strongest induced operons at no/low iron conditions in all three transcriptome analyses (Ho and Ellermeier, 2015; Hastie et al., 2018) was the one encoding the catecholate siderophore import system YclNOPQ (CDIF630erm_001824 – 01827). This represents a high affinity iron import system induced at low iron conditions and in the fur mutant which allows uptake of iron at low bioavailability.

The precursor of many catechol siderophores is spermidine (Datta and Chakrabartty, 2014). Interestingly, the spermidine biosynthesis genes speAHEB (CDIF630erm_01008 – 01022) and spermidine/putrescine transporter genes potABCD (CDIF630erm_01160 – 01163) were significantly induced on the transcriptome (spe, Hastie et al., 2018 and pot) and the proteome (only spe) level (Table 1 and Figure 3). In agreement, significantly increased levels of spermidine, spermine and putrescine were detected in the metabolome of iron limited C. difficile cells (Supplementary Table S6). Already in the nineties an increase in polyamines in bacterial cell grown under iron-limited conditions was studied (Bergeron and Weimar, 1991). A similar close relationship between intracellular iron and polyamine content was described for cancer cells (Bae et al., 2018; Lane et al., 2018). Interestingly, siderophores like petrobactin (Lee et al., 2007), alcaligin (Challis, 2005) are formed from polyamines. Others like vibriobactin and vulnibactin contain polyamine backbones (Shah and Swiatlo, 2008; Bergeron et al., 2011). However, the protective function of polyamines during stress situation and their importance for the infection process of many bacteria have been widely described (Shah and Swiatlo, 2008).

The fur Mutant Lost Most of Its Flagella and Motility

Comparative inspection of the wild type and fur mutant C. difficile strains using scanning electron microscopy revealed obvious differences with regard to the presence of flagella. Scanning electron microscopy revealed a significant loss of flagella in the fur mutant compared to the wild type C. difficile (Figure 4B). Negative staining (Figure 4C) also depicted less flagellation of the fur mutant and no detectable other appendage-like structures on the surface like pili or fimbriae. Motility assay revealed in agreement with the electron microscopy analyses, that the fur mutant was highly impaired in motility (Figure 4A). Interestingly, the two flagella operons were also subject to Fur-mediated gene regulation, one (CDIF630erm_00375 – 00395) was found Fur-repressed, while the other (CDIF630erm_00348 - 00361) was identified as Fur-induced. Interestingly, latter operon contained a Fur box upstream of CDIF630erm_00348. The missing Fur-dependent induction of this operon might have caused the observed phenotype. The proteome data partially confirmed this assumption. Most likely, additional unknown factors are required. Remarkably, the gene for the pleiotropic regulator SinR (CDIF630erm_02447) was found overexpressed under iron limiting conditions. One function of the SinR regulator in C. difficile is the induction of flagella formation and motility via the control of c-di-GMP levels (Girinathan et al., 2018). Similarly, proline iminopeptidase (CDIF630erm_02215), catalyzing the removal of N-terminal proline residues from peptides, was described to be involved in Xanthomonas campestris motility via influencing c-di-GMP levels (Khan et al., 2018). The corresponding plp gene and a TetR family transcriptional regulator were found induced under low iron conditions. Pili gene transcription (CDIF630erm_03817 – 03826) was found reduced in the fur mutant (Table 1). This is in agreement with the electron microscopy inspection of the fur mutant (Figure 4C). Due to their extracellular location only one pilus protein was detected by the proteomics approach, but as expected solely in the wild type strain (OFF). Due to a missing potential Fur box upstream the pil operon the observed regulation might be of indirect nature.

FIGURE 4

Low Iron Conditions Induce Major Re-Arrangements of the Energy Metabolism Partially Regulated by Fur

The basic principles of energy generation of Clostridia differs significantly from those of eukaryotes or other prokaryotes. Some of these bacteria mainly generate their energy in form of amino acid fermentation using two coupled reactions previously called Stickland reaction (Stickland, 1934). ATP is formed at the substrate level and using a proton/sodium gradient at the membrane. In principle, during the first oxidative part of the reaction, the first amino acid gets deaminated to form an a-keto acid with the concurrent transfer of the electrons to a carrier like NAD+. Subsequently, the decarboxylation of the a-keto acid is linked with the formation of a coenzyme A ester, which in turn is converted into an acyl-phosphate. The final transfer of the activated phosphate residue to ADP yields ATP. In the reductive part of the pathway the second amino acid gets reduced by the formed electrons and deaminated. Sometimes this process is again coupled to ATP generation (Durre, 2014). During the analysis of butyrate formation in C. difficile the enzyme butyryl-CoA dehydrogenase (Bcd) was identified as an electron bifurcating stable complex with the flavoproteins EtfA and EtfB (Aboulnaga et al., 2013). The complex oxidizes NADH and transfers two electrons to the first flavin (β-flavin), which bifurcates one electron to ferredoxin and one electron to a second flavin (α-flavin). After two such rounds the completely reduced a-flavin transfers two electrons further to the third flavin (s-flavin) of the complex, which finally reduces crotonyl-CoA to butyryl-CoA (Chowdhury et al., 2014; Demmer et al., 2017). Most importantly, formed reduced ferredoxins are the substrate of the membrane spanning ferredoxin-NAD+ reductase complex (Rnf) which couples the electron transfer from the ferredoxin to NAD+ with the generation of a proton or sodium gradient at the membrane (Biegel and Muller, 2010; Tremblay et al., 2012; Mock et al., 2015; Chowdhury et al., 2016). The generated sodium gradient drives ATP generation via a sodium-dependent ATPase (Buckel and Thauer, 2013; Buckel and Thauer, 2018).

Clostridioides difficile possesses three different EtfAB systems. The first is encoded downstream the bcd2 gene encoding butyryl-CoA dehydrogenase (CDIF630erm_01194 – 01199), the second (CDIF630erm_01319 – 01320) in an operon with lactate racemase (LarA, CDIF630erm_01318) and a lactate dehydrogenase (CDIF630erm_01321) and the third downstream of acdB encoding a short chain acyl-CoA dehydrogenase involved in the conversion of 2-enoyl-3-phenylpropionyl-CoA/isocaprenoyl-CoA into 3-phenylpropionyl-CoA/isocaproyl-CoA during phenylalanine/leucine fermentation with formation of 3-phenylpropionate/isocaproate (Elsden and Hilton, 1978; Britz and Wilkinson, 1982; Kim et al., 2006). The selenoprotein D-proline reductase (PrdABCDE) catalyzes the reductive ring cleavage of D-proline to form 5-aminovalerate. As typical Stickland reaction it is coupled to the oxidation of other amino acids, but also formate can serve as electron donor (Kabisch et al., 1999). First proline racemase (PrdF) converts L-proline into D-proline (Wu and Hurdle, 2014). Already in the eighties it was shown that proline reduction is coupled to proton motive force generation (Lovitt et al., 1986). However, the enzyme complex does not reduce ferredoxin and was proposed to directly interact with the membrane-localized, proton/sodium pumping Rnf complex (Jackson et al., 2006). Glycine reductase (GrdABCDE) catalyzes the reductive deamination of glycine to form acetylphosphate and ammonia with the oxidation of thioredoxin (TrxA2, TrxB3) (Andreesen, 2004). The influence of iron on the fermentative metabolism of Clostridium acetobutylicum was already described in the eighties (Bahl et al., 1986).

At low iron conditions the ferredoxin-dependent pathways of phenylalanine, leucine (hadAIBCB, etfBA, CDIF630erm_00523 – 00529), glycine degradation (grdDCBAE,trxBA (CDIF630erm_02587 – 02597) and butyrate fermentation (CDIF630erm_01194 – 01199) with the formation of 3-phenylpropionate, isocaproate, butyrate, 5-methylcaproate, valerate and acetate (CDIF630erm_01194 – 01199, CDIF630erm_02577 – 02583) were significantly reduced, while the proline reductase (prdFEDBARC, CDIF630erm_03533 – 03544) and Rnf complex encoding operons (rnfCDGEAB, CDIF630erm_01284 – 01289) were induced in C. difficile (Table 1). Correspondingly, the highest increase in metabolite concentration was observed for 5-aminovalerate, the product of up-regulated proline utilization, when the lower biomass responsible for its production is taken into account. In agreement, the substrates of the reduced pathways phenylalanine, leucine, glycine and some initial intermediates (phenylpyruvate, 2-oxo-isocaproate, 3-hydroxybutyryl-CoA, crotonyl-CoA) were found accumulated. At the same time some end product like isocaproate and butyrate were found reduced (Figure 3).

Moreover, the synthesis of the flavodoxin (FldX, CDIF630erm_02217) and of enzymes of riboflavin biosynthesis (ribHBAED, CDIF630erm_01882 – 01885) was found significantly enhanced. Interestingly, flavodoxins can replace ferredoxins as electron donors for the proton/sodium ion pumping ferredoxin-NAD+ reductase (Rnf) (Chowdhury et al., 2016). Consequently, one explanation for the increased formation of flavodoxins is the replacement of iron-containing ferredoxin as electron donors at the Rnf-complex. The EtfAB (CDIF630erm_01319 - 01321) containing system with nickel-dependent lactate racemase (CDIF630erm_01318) was found induced under low iron conditions (Weghoff et al., 2015). Possibly, the yet unknown function contributes to the overall change or the system uses flavodoxin as natural electron acceptors. Interestingly, a change in ATPase also accompanied the switch from high to low iron conditions. Under low iron conditions, where the directly Rnf complex-coupled proline reductase was found enhanced, an F0F1-type, sodium-dependent ATP forming ATPase (atpCDGAHFEB, CDIF630erm_03778 – 03785) was found induced. Under high iron conditions Fur-induces the formation of a V-type, mostly proton-pumping, ATP-consuming ATPase (atpDBAFCEKI, CDIF630erm_03237 – 03245) was preferentially produced. Promoter sequences upstream of the latter genes contained a potential Fur biding site. Clearly, under low iron conditions C. difficile significantly reduced the formation of most iron-requiring, ferredoxin-dependent processes including phenylalanine/leucine utilization via AcdB/EtfA1B1 and butyrate/caproate/valerate formation via Bcd2, EtfA3B3 (Table 1 and Figure 3). Only lactate formation via Ldh/EtfA4B4 was found. Finally, the transcripts for an F0F1-type, sodium-dependent ATP forming ATPase (atpCDGAHFEB, CDIF630erm_03778 – 03785) were more abundant, while the formation of a V-type, mostly proton-pumping, ATP-consuming ATPase (atpDBAFCEKI, CDIF630erm_03237 – 03245) was reduced. Obviously, the ferredoxin-independent process of Rnf-complex coupled proline utilization was found enhanced and with it the formation of an ATP forming proton/sodium–driven ATPase. The oligopeptide transporter OppBCAD (CDIF630erm_0972 - 0975) was found reduced.

Looking at the identified potential Fur binding sites, most of the observed changes are not directly regulated by Fur. Two open readings frames upstream of the had operon and the hydroxybutyrate metabolizing enzymes encoding operon possessed potential Fur binding sites (Table 1). Additionally, the flavodoxin gene fldX contained a Fur-box upstream its coding region. Perhaps, known regulators including PrdR, CodY, CcpA or Rex are involved in the detection of the drastic physiological changes accompanying the outlined adaptation process (Bouillaut et al., 2015). Currently, the relationship between membrane protein function and lipid composition becomes true. In this context, the major operon of fatty acid biosynthesis (fapR, plsX, fabHKDG, acpP, fabF, CDIF630erm_01326 – 01333) was up-regulated at the transcriptional level during iron limiting conditions (Table 1). Obviously, a re-structuring of the membrane is required for the overall adaptation of multiple membrane associated metabolic processes.

Iron Requiring Metabolic Processes of the Central Metabolism and of CO Oxidation Are Significantly Downregulated at Low Iron Conditions

Clostridioides difficile is utilizing pyruvate via the radical enzyme pyruvate formate-lyase, which forms in the presence of coenzyme A acetyl-CoA and formate (Figure 3). Formate gets subsequently oxidized by the formate dehydrogenase H to CO2 and protons. The [NiFe] Hydrogenase Hyd reduces protons to molecular hydrogen (Shafaat et al., 2013; Pinske and Sawers, 2016). Pyruvate formate-lyase (PflD) requires an [4Fe-4S] cluster containing activating enzyme (PflC, PflD1) for the formation of the catalytic glycyl radical (Crain and Broderick, 2014). Formate lyase H (FdhF) is described as a MoCo-containing selenoprotein with a single [4Fe-4S] cluster (Pinske and Sawers, 2016). FdhD is a sulfurtransferase which transfers the sulfur residing on the desulfurase IscS to FdhF (Thome et al., 2012). The [NiFe] Hydrogenase (HydN1AN2) contains 3 different iron-sulfur clusters and heme (Shafaat et al., 2013; Pinske and Sawers, 2016). The whole array of Fe-containing enzymes and their activators were found strictly down-regulated under low iron conditions (Supplementary Table S8). The utilization of glucose via pyruvate-formate lyase (PflD, CDIF630erm_03582 – 03583), with formate dehydrogenase and a hydrogenase (Hyd, Fdh, CDIF630erm_03614 – 03619) was downregulated mainly at the transcript level at low iron condition (Table 1 and Figure 3). Consequently, the whole flux toward formate and hydrogen was significantly blocked at low iron conditions, glucose and pyruvate accumulated (Supplementary Table S5). The overall flux through the glycolysis seemed to be reduced since also glucose accumulated 2.17-fold (Figure 3). In agreement the synthesis of the enzyme for glycogen formation from glucose (GlyCDAP) was also diminished by 3.5-fold. Again, an iron-requiring metabolic pathway was shut down at low iron conditions. Fur-dependent regulation might be mediated via a potential Fur-box found upstream the hydrogenase gene hydN2 and the ATPase gene atpA. CO dehydrogenase (CooSC, CDIF630erm_00832 – 00833) formation was found reduced at the transcriptional and proteomic level. Carbon monoxide dehydrogenase CooSF contains 5 [Fe-S] cluster and catalyzes the oxidation of CO using water with the formation of CO2 and hydrogen (Dobbek et al., 2001). Like the hydrogen utilizing hydrogenase, carbon monoxide dehydrogenase was down-regulated at the transcriptional and proteomic level.

Cell Wall Restructuring and the Protection Against Antibiotics and CAMPs

Obviously, the low iron stress was counteracted via increased resistance to external attacks. Firstly, the transcription of the dtl operon (dtlCBAD, CDIF630erm_03118 - 03122) involved in the resistance to the collection antimicrobial peptides (CAMP) was enhanced during low iron conditions (McBride and Sonenshein, 2011). The enzymatic system encoded by the corresponding genes is responsible for the D-alanylation of lipoteichoic acids. The D-alanine-poly(phosphoriboto) ligase DltA ligates D-alanine to the carrier protein DltC. Aided by DltB, DltC transferres the D-alanine further to undecaprenyl phosphate and transverses to the membranes. Finally, the D-alanine transferases DltD is involved in the final release of the lipoteichoic acids outside the cell. Similarly, the so called vancomycin resistance gene cluster (vanGYTG, CDIF630erm_01803 – 01805) was found induced at the transcriptional level. The encoded proteins VanG (D-Ala:D-Ser ligase), VanXY (D,D-depeptidase), and VanT (D-Ser racemase) acting on the peptidoglycan, were found all functional in C. difficile before, however, confer only low resistance to vancomycin (Ammam et al., 2013; Peltier et al., 2013).

We challenged the wild type and the fur mutant with below MIC50 amounts of vancomycin and the CAMP polymyxin B as determined before (McBride and Sonenshein, 2011; Ammam et al., 2013). In the presence of 0.3 mg vancomycin/l a delayed growth of the wild type and the fur mutant with an visibly increased sensitivity of the fur mutant strain especially after 18 h to vancomycin treatment was observed. The treatment of both strains with 150 mg/l polymyxin resulted in normal growth of the wild type and significantly inhibited growth of the fur mutant (Figure 5).

FIGURE 5

Additionally, two potential ABC transporter systems of the bacitracin/multidrug family (CDIF630erm_00443 – 00445,CDIF630erm_00938 – 00943) and one multi antimicrobial extrusion protein with a downstream MarR family transcriptional regulator gene (CDIF630erm_03501 – 03502) were also found approximately 2- to 3-fold induced at the transcriptional level (Table 1). Multiple genes encoding enzyme of cell wall biosynthesis and modification (murG, murD, mraY, murF, CDIF630erm_02905 – 02909, manC, pgm, mviN, glmU, prs) were two–fourfold transcriptionally up-regulated under low iron conditions. A mutated murG gene was selected to mediate in decreased susceptibility to vancomycin (Leeds et al., 2014). Deletion of the manC gene in Corynebacterium glutamicum resulted in a slow growing mutant, showing the essential role of the targeted pathway (Mishra et al., 2012). Interestingly, disruption of GDP-mannose synthesis in Streptomyces coelicolor resulted in an increased susceptibility to antibiotics of the bacterium (Howlett et al., 2018). The last gene of the operon encoding the transmembrane virulence factor MviN was shown to be essential in C. difficile (Chu et al., 2016). Antisense RNA mediated down-regulation of mviN resulted in a morphology defects, retarded growth and decreased PSII (integral part of the cell wall anchored glycopolymers) formation and surface deposition (Chu et al., 2016). The bifunctional N-acetyltransferase/uridylyltransferase GlmU (CDIF630erm_03829) catalyzes the transfer of an acetyl from acetyl-coenzyme A to glucosamine 1-phosphate to form N-acetylglucosamine 1-phosphate during cell wall biosynthesis. The protein is necessary for the infection of various pathogenic bacteria, including Mycobacterium tuberculosis, Yersinia pestis, Haemophilus influenzae and Xanthomonas oryzae (Buurman et al., 2011; Min et al., 2012; Patin et al., 2015), it serves as target for the antimicrobial treatment of Mycobacteria (Sharma and Khan, 2017). The glmU gene obviously forms an operon with the prs gene (CDIF630erm_03828) encoding ribose-phosphate pyrophosphokinase that catalyzes the conversion of ribose-5-phosphate into phosphoribosyl pyrophosphate during nucleotide biosynthesis. The prs gene was one of the major up-regulated genes of Bacillus thuringiensis in response to erythromycin treatment (Zhou et al., 2018). Both genes were found up-regulated under low iron conditions. The phosphotransferase uptake system for mannose/fructose/sorbose (CDIF630erm_00408 – 00413) was also found enhanced two–threefold at the transcriptional level. Mannose-derived and guanosine-activated compounds are important constituents of the Gram-positive cell wall. In contrast, the genes for the enzymes N-acetylglucosamine-6-phosphate deacetylase (NagA) and the N-acetylglucosamine-6-phosphate deaminase (NagB) (CDIF630erm_01146 – 01147) involved in cell wall degradation and restructuring were found fourfold down-regulated. The enzyme catalyzes the conversion of N-acetyl-D-glucosamine-6-phosphate via D-glucosamine-6-phosphate to D-fructose-6-phosphate during cell recycling. Interestingly, the promoter of the glmU gene is the only gene regulatory element with a potential Fur binding site of almost all iron regulated genes of cell wall metabolism. Obviously, the cell wall is restructured to protect the bacterium against various external challenges. At the same time cell wall degradation and recycling is stopped. Interestingly, the genes for extracytoplasmic function (ECF) sigma factor sV (csfV) and the corresponding anti ECF sigma factor RsiV were found enhanced at the transcriptional level. The sigma factor sV regulates peptidoglycan deacetylation and lysozyme resistance (Ho and Ellermeier, 2011; Ho et al., 2014). An iron-regulated gene encoding a peptidyl-prolyl isomerase is encoded by the gene upstream of both genes. The corresponding promoter carried a potential Fur binding site.

Nucleotide Biosynthesis, CRISPR/Cas System and Prophage Cluster Regulation

Dihydroorotate dehydrogenase (PyrDK), aspartate carbamoyltransferase (PyrB), and orotate phosphoribosyltransferase (PyrE), all enzyme of pyrimidine biosynthesis (pyrBKDE, CDIF630erm_00305 – 00308) were found induced at the transcript level under low iron conditions. Interestingly, in other bacteria dihydroorotate dehydrogenase (PyrDK) channels abstracted electrons directly into electron transfer chains and contributes to proton/sodium gradient formation (Reis et al., 2017). Furthermore, the transcripts from an operon (purECFGNHDL, CDIF630erm_00340 – 00347) involved in purine biosynthesis were found more abundant (Table 1). The purine GTP serves as precursor of riboflavin biosynthesis, which also was found enhanced under low iron conditions. Both operons revealed Fur binding site containing promoters. The bacterial immunity system against phage infections CRISPR/Cas (CDIF630erm_03259 – 03266) was found approximately twofold down-regulated at the transcriptional and proteomic level (Hargreaves et al., 2014). The prophage encoded by CDIF630erm_01522 – 01532 was also found down-regulated. The corresponding promoter of the operon possessed a conserved Fur binding site.

Discussion

The highly specialized energy metabolism of C. difficile mainly relies on multiple ferredoxin-mediated amino acid utilizing reactions, and on pathways harboring various iron-sulfur cluster containing enzymes (see Figure 3 and Supplementary Table S8). Overall, it is highly iron-dependent. In an anaerobic organism, this usually represents a feasible and effective strategy. There are two major drawbacks of this highly specialized lifestyle. (1) Oxygen is inactivating many of the employed processes. (2) Iron is essential for this type of energy metabolism. We investigated here the critical scenario of low iron conditions. It was no surprise that an initial stress response for the acquisition of iron (iron transporter on!) was observed. Maybe, the production of polyamines has something to do with iron storage and acquisition. But in parallel, a major rebuilding of the central energy metabolism occurred. All ferredoxin-dependent amino acid (Phe, Leu, Gly) utilizing processes were drastically reduced. Flavodoxin as an alternative was brought into the game. Similarly, glucose utilization via pyruvate-formate-lyase, formate dehydrogenase, and hydrogenase, all multi-Fe-S-enzymes, was reduced. Instead, proline utilization directly coupled to the sodium ion/proton pumping RNF complex was strongly enhanced. Thus, the switch from more substrate phosphorylation dominated energy generation to membrane potential based processes obviously required the utilization of a different, membrane potential-dependent ATP-forming ATPase. Most likely, even the membrane composition was adjusted appropriately. Finally, the energy consuming process of motility via flagella movement was reduced. However, the transition period for the adaptation to low iron conditions represents a period of metabolic weakness and physical vulnerability. Here, C. difficile “protects the gates,” changing drastically the composition of the cell wall. Protection against antibiotics from other microorganisms of the microbiome, against CAMPs or molecules of the immune system of the host are the major task. And what has Fur to do with all of it? It is the major player, directly and indirectly. Proposed Fur binding sites identified central adaptation processes as directly Fur-controlled. Nevertheless, especially in the complex adaptation of the energy metabolism several indirect regulatory scenarios can be assumed.

In the closely related C. acetobutylicum the strong induction flavodoxins and riboflavin biosynthesis under iron limited conditions was also observed besides the expected increase of iron uptake systems (Vasileva et al., 2012). Additionally, a few metabolic enzymes involved in energy generation were found iron controlled, however, not to the degree observed in this study for C. difficile. The major difference of C. difficile to many other pathogenic bacteria is their aerobic/facultative anaerobic life style. Under these condition iron uptake and storage is connected to ROS formation. Consequently, these bacteria use Fur for the control of superoxide dismutase, catalase, or hydroperoxidase formation (Troxell and Hassan, 2013). Nevertheless, a strict co-regulation of the TCA cycle during virulence by Fur was observed for Staphylococcus epidermidis and Vibrio cholera (Troxell and Hassan, 2013). Finally, multiple other bacteria employ completely different systems (Irr, RirA, and IscR) for their iron response (Rudolph et al., 2006; Santos et al., 2015; Mandin et al., 2016). Consequently, the observed adaptation of C. difficile to low iron conditions partly mediated by Fur is the result of its unique life style and metabolism.

Statements

Author contributions

AN, MaB, and PD were responsible for the RNA-Seq experiments. CL, KR, SS, SM, DB, and AO performed and interpreted the proteomic approaches. MN-S performed and interpreted the metabolome experiments, bioinformatics came from DE and MiB. MR, MaB and AMM did the electron microscopy studies. DJ, MN-S, MJ, JMBdA and AMM were responsible for data integration and manuscript writing.

Funding

This work was funded by the Federal State of Lower Saxony, Niedersächsisches Vorab CDiff and CDInfect projects (VWZN2889/3215/3266). Furthermore, grants for open access publication were made available by the TU Braunschweig central library.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2018.03183/full#supplementary-material

Figure S1

Clostron-based knock out of the Clostridioides difficile fur gene. On the left side the mutagenesis strategy and the theoretical PCR-based control with all necessary primers and resulting PCR products are depicted. Corresponding primers and test condition are outlined in the method section. On the right side an experimental PCR-based verification of the generated C. difficile fur mutant is shown. The agarose gel with stained DNA from the analysis of wild type versus fur mutant clones shows in lane A the wild type DNA control with an expected PCR product of 394 bp. Lane B displays a PCR product of 2,194 bp from the fur mutant strain indicating desired mutational insertion, lane C shows the corresponding intron–exon junction PCR product of 410 bp, and lane D displays the spliced ErmRAM marker PCR product of 900 bp. Lane M represents the GeneRuler Ladder Mix, Fermentas (Thermo Fisher Scientific, Darmstadt, Germany).

Figure S2

Growth of wild type and fur mutant C. difficile in BHI medium. C. difficile 630Δerm and corresponding fur mutant were grown in BHI medium for 24 h. Growth in anaerobic flasks was monitored every 2 h in at least 3 independent cultivations by measuring the optical density of the culture at 600 nm. The black curve represents 630Δerm growth and the green curve the growth of the corresponding fur mutant. Standard deviations are given.

Figure S3

Complementation of the fur mutant with fur in trans. Growth on high iron containing minimal medium of C. difficile wild type (black), the corresponding fur mutant (green), and the fur mutant complemented in trans with the fur gene (red) was monitored by absorbance measurements at 600 nm (left, in absorbance units) over the time period indicated (bottom).

Figure S4

Comparison of the growth behavior of C. difficile wild type (black) and the corresponding fur mutant strain (green) utilizing different iron sources. C. difficile 630Δerm and the corresponding fur mutant were grown for 24 h in CDM medium with different iron sources. The iron sources were: FeSO4(A), Fe citrate (B), hemin (C), FeCl3(D), transferrin (E), and ferritin (F). Growth was monitored spectroscopically every 2 h in anaerobic flasks in at least 3 independent cultivations. Standard deviations are given.

Figure S5

Principle component analysis (PCA) of the RNA-Seq based transcriptome samples from this study in biological triplicates. Cultures were grown in CDM medium under high (760 μg/l) and low (11 μg/l) iron conditions, harvested at mid-log phase (see Figure 1) and used for transcriptome (RNA-Seq) analyses. Obtained results were used for PCA. Orange circles represent wild type grown under high iron, blue circles indicate wild type grown under low iron, orange squares stand for the results for the fur mutant grown under high iron conditions, and the blue squares are for the fur mutant grown under low iron conditions.

Table S1

Comparative transcriptome (RNA-Seq) analysis of C. difficile wild type grown at low and high iron conditions. For details, please consult the Section “Materials and Methods” and “Results”.

Table S2

Comparative transcriptome (RNA-Seq) analysis of C. difficile wild type grown at high iron versus the fur mutant at high iron conditions. For details, please consult the Section “Materials and Methods” and “Results.”

Table S3

Comparative transcriptome (RNA-Seq) analysis of the C. difficile fur mutant grown at low and high iron conditions. For details, please consult the Section “Materials and Methods” and “Results”.

Table S4

Comparative proteome analysis of C. difficile wild type and the fur mutant grown at low and high iron conditions. For details, please consult the Section “Materials and Methods and “Results.”

Table S5

Genome annotation conversion table for the C. difficile 630 (lane A) and C. difficile 630Δerm (B). Given is further the gene name (lane C), the start point (D) and end point (E) on the genome, the coding strand (F), the Refseq No. (G), the EC No. of the encoded enzyme (H), the TIGR main role (I), the TIGR minor role (J), the GO terms (K), the name of the gene product (L) and the protein sequence (M).

Table S6

Comparative metabolome and exo-metabolome analysis of C. difficile wild type and the fur mutant grown at low and high iron conditions. For details, please consult the Section “Materials and Methods” and “Results”.

Table S7

Bioinformatics-based investigation of the Fur-binding sites in the C. difficile 630Δerm genome. Listed are all found Fur binding sites found with the consensus shown in Figure 2 upstream from the indicated genes/operons. The results for the Fur binding sites described by Dubois et al. (2016) and from Ho and Ellermeier (2015) are included. For details, please consult the Section “Materials and Methods” and “Results”.

Table S8

Iron-binding proteins in C. difficile. Locus tags of Clostridioides difficile 630Δerm and their annotation and bound iron as detected by InterPro Scan. Green highlighted locus tags were found regulated in the present experimental set-up (see Table 1).

References

  • 1

    AboulnagaE.-H.PinkenburgO.SchiffelsJ.El-RefaiA.BuckelW.SelmerT. (2013). Effect of an oxygen-tolerant bifurcating butyryl coenzyme A dehydrogenase/electron-transferring flavoprotein complex from Clostridium difficile on butyrate production in Escherichia coli.J. Bacteriol.19537043713. 10.1128/JB.00321-13

  • 2

    AmmamF.Meziane-CherifD.Mengin-LecreulxD.BlanotD.PatinD.BonecaI. G.et al (2013). The functional vanGCD cluster of Clostridium difficile does not confer vancomycin resistance.Mol. Microbiol.89612625. 10.1111/mmi.12299

  • 3

    AndreesenJ. R. (2004). Glycine reductase mechanism.Curr. Opin. Chem. Biol.8454461. 10.1016/j.cbpa.2004.08.002

  • 4

    Argiris Symeonidis and Markos Marangos (2012). “Iron and microbial growth,” inInsight and Control of Infectious Disease in Global Scenario, ed.RoyP. K. (Rijeka: In Tech), 289332.

  • 5

    AwadM. M.CheungJ. K.TanJ. E.McEwanA. G.LyrasD.RoodJ. I. (2016). Functional analysis of an feoB mutant in Clostridium perfringens strain 13.Anaerobe411017. 10.1016/j.anaerobe.2016.05.005

  • 6

    BaeD. H.LaneD. J. R.JanssonP. J.RichardsonD. R. (2018). The old and new biochemistry of polyamines.Biochim. Biophys. Acta186220532068. 10.1016/j.bbagen.2018.06.004

  • 7

    BahlH.GottwaldM.KuhnA.RaleV.AnderschW.GottschalkG. (1986). Nutritional factors affecting the ratio of solvents produced by Clostridium acetobutylicum.Appl. Environ. Microbiol.52169172.

  • 8

    BaileyT. L.BodenM.BuskeF. A.FrithM.GrantC. E.ClementiL.et al (2009). MEME SUITE: tools for motif discovery and searching.Nucleic Acids Res.37W202W208. 10.1093/nar/gkp335

  • 9

    BartlettJ. G.GerdingD. N. (2008). Clinical recognition and diagnosis of Clostridium difficile infection.Clin. Infect. Dis.46(Suppl. 1), S12S18. 10.1086/521863

  • 10

    BenjaminiY.HochbergY. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing.J. R. Stat. Soc.57289300. 10.1111/j.2517-6161.1995.tb02031.x

  • 11

    BentonH. P.WongD. M.TraugerS. A.SiuzdakG. (2008). XCMS2: processing tandem mass spectrometry data for metabolite identification and structural characterization.Anal. Chem.8063826389. 10.1021/ac800795f

  • 12

    BergeronR. J.SinghS.BhartiN. (2011). Synthesis of heterobactins A and B and nocardia heterobactin.Tetrahedron6731633169. 10.1016/j.tet.2011.03.003

  • 13

    BergeronR. J.WeimarW. R. (1991). Increase in spermine content coordinated with siderophore production in Paracoccus denitrificans.J. Bacteriol.17322382243. 10.1128/jb.173.7.2238-2243.1991

  • 14

    BiegelE.MullerV. (2010). Bacterial Na+-translocating ferredoxin:NAD+ oxidoreductase.Proc. Natl. Acad. Sci. U.S.A.1071813818142. 10.1073/pnas.1010318107

  • 15

    BouillautL.DuboisT.SonensheinA. L.DupuyB. (2015). Integration of metabolism and virulence in Clostridium difficile.Res. Microbiol.166375383. 10.1016/j.resmic.2014.10.002

  • 16

    BraunV.HantkeK. (2011). Recent insights into iron import by bacteria.Curr. Opin. Chem. Biol.15328334. 10.1016/j.cbpa.2011.01.005

  • 17

    BritzM. L.WilkinsonR. G. (1982). Leucine dissimilation to isovaleric and isocaproic acids by cell suspensions of amino acid fermenting anaerobes: the Stickland reaction revisited.Can. J. Microbiol.28291300. 10.1139/m82-043

  • 18

    BuckelW.ThauerR. K. (2013). Energy conservation via electron bifurcating ferredoxin reduction and proton/Na+ translocating ferredoxin oxidation.Biochim. Biophys. Acta182794113. 10.1016/j.bbabio.2012.07.002

  • 19

    BuckelW.ThauerR. K. (2018). Flavin-based electron bifurcation, a new mechanism of biological energy coupling.Chem. Rev.11838623886. 10.1021/acs.chemrev.7b00707

  • 20

    BurkeK. E.LamontJ. T. (2014). Clostridium difficile infection: a worldwide disease.Gut Liver816. 10.5009/gnl.2014.8.1.1

  • 21

    BuurmanE. T.AndrewsB.GaoN.HuJ.KeatingT. A.LahiriS.et al (2011). In vitro validation of acetyltransferase activity of GlmU as an antibacterial target in Haemophilus influenzae.J. Biol. Chem.2864073440742. 10.1074/jbc.M111.274068

  • 22

    CernatR. C.ScottK. P. (2012). Evaluation of novel assays to assess the influence of different iron sources on the growth of Clostridium difficile.Anaerobe18298304. 10.1016/j.anaerobe.2012.04.007

  • 23

    ChallisG. L. (2005). A widely distributed bacterial pathway for siderophore biosynthesis independent of nonribosomal peptide synthetases.Chembiochem6601611. 10.1002/cbic.200400283

  • 24

    ChowdhuryN. P.KlomannK.SeubertA.BuckelW. (2016). Reduction of flavodoxin by electron bifurcation and sodium ion-dependent reoxidation by NAD+ catalyzed by ferredoxin-NAD+ reductase (Rnf).J. Biol. Chem.2911199312002. 10.1074/jbc.M116.726299

  • 25

    ChowdhuryN. P.MowafyA. M.DemmerJ. K.UpadhyayV.KoelzerS.JayamaniE.et al (2014). Studies on the mechanism of electron bifurcation catalyzed by electron transferring flavoprotein (Etf) and butyryl-CoA dehydrogenase (Bcd) of Acidaminococcus fermentans.J. Biol. Chem.28951455157. 10.1074/jbc.M113.521013

  • 26

    ChuM.MallozziM. J.RoxasB. P.BertoloL.MonteiroM. A.AgellonA.et al (2016). A Clostridium difficile cell wall glycopolymer locus influences bacterial shape, polysaccharide production and virulence.PLoS Pathog.12:e1005946. 10.1371/journal.ppat.1005946

  • 27

    CornelisP.WeiQ.AndrewsS. C.VinckxT. (2011). Iron homeostasis and management of oxidative stress response in bacteria.Metallomics3540549. 10.1039/c1mt00022e

  • 28

    CrainA. V.BroderickJ. B. (2014). Pyruvate formate-lyase and its activation by pyruvate formate-lyase activating enzyme.J. Biol. Chem.28957235729. 10.1074/jbc.M113.496877

  • 29

    DannheimH.RiedelT.Neumann-SchaalM.BunkB.SchoberI.SproerC.et al (2017a). Manual curation and reannotation of the genomes of Clostridium difficile 630Deltaerm and C. difficile 630.J. Med. Microbiol.66286293. 10.1099/jmm.0.000427

  • 30

    DannheimH.WillS. E.SchomburgD.Neumann-SchaalM. (2017b). Clostridioides difficile 630Deltaerm in silico and in vivo – quantitative growth and extensive polysaccharide secretion.FEBS Open Bio7602615. 10.1002/2211-5463.12208

  • 31

    DattaB.ChakrabarttyP. K. (2014). Siderophore biosynthesis genes of Rhizobium sp. isolated from Cicer arietinum L.3 Biotech4391401. 10.1007/s13205-013-0164-y

  • 32

    DemmerJ. K.Pal ChowdhuryN.SelmerT.ErmlerU.BuckelW. (2017). The semiquinone swing in the bifurcating electron transferring flavoprotein/butyryl-CoA dehydrogenase complex from Clostridium difficile.Nat. Commun.8:1577. 10.1038/s41467-017-01746-3

  • 33

    DengZ.WangQ.LiuZ.ZhangM.MachadoA. C.ChiuT. P.et al (2015). Mechanistic insights into metal ion activation and operator recognition by the ferric uptake regulator.Nat. Commun.6:7642. 10.1038/ncomms8642

  • 34

    DobbekH.SvetlitchnyiV.GremerL.HuberR.MeyerO. (2001). Crystal structure of a carbon monoxide dehydrogenase reveals a [Ni-4Fe-5S] cluster.Science29312811285. 10.1126/science.1061500

  • 35

    DreslerJ.KrutovaM.FucikovaA.KlimentovaJ.HruzovaV.DuracovaM.et al (2017). Analysis of proteomes released from in vitro cultured eight Clostridium difficile PCR ribotypes revealed specific expression in PCR ribotypes 027 and 176 confirming their genetic relatedness and clinical importance at the proteomic level.Gut Pathog.9:45. 10.1186/s13099-017-0194-9

  • 36

    DuboisT.Dancer-ThibonnierM.MonotM.HamiotA.BouillautL.SoutourinaO.et al (2016). Control of Clostridium difficile physiopathology in response to cysteine availability.Infect. Immun.8423892405. 10.1128/IAI.00121-16

  • 37

    DurreP. (2014). Physiology and sporulation in Clostridium.Microbiol. Spectr.2:TBS0010.2012. 10.1128/microbiolspec.TBS-0010-2012

  • 38

    EdgarR.DomrachevM.LashA. E. (2002). Gene Expression omnibus: NCBI gene expression and hybridization array data repository.Nucleic Acids Res.30207210. 10.1093/nar/30.1.207

  • 39

    ElsdenS. R.HiltonM. G. (1978). Volatile acid production from threonine, valine, leucine and isoleucine by clostridia.Arch. Microbiol.117165172. 10.1007/BF00402304

  • 40

    FillatM. F. (2014). The FUR (ferric uptake regulator) superfamily: diversity and versatility of key transcriptional regulators.Arch. Biochem. Biophys.5464152. 10.1016/j.abb.2014.01.029

  • 41

    GirinathanB. P.OuJ.DupuyB.GovindR. (2018). Pleiotropic roles of Clostridium difficile sin locus.PLoS Pathog.14:e1006940. 10.1371/journal.ppat.1006940

  • 42

    HastieJ. L.HannaP. C.CarlsonP. E. (2018). Transcriptional response of Clostridium difficile to low iron conditions.Pathog. Dis.76:fty009. 10.1093/femspd/fty009

  • 43

    HargreavesK. R.KropinskiA. M.ClokieM. R. (2014). Bacteriophage behavioral ecology: how phages alter their bacterial host’s habits.Bacteriophage4:e29866. 10.4161/bact.29866

  • 44

    HeapJ. T.CartmanS. T.KuehneS. A.CooksleyC.MintonN. P. (2010). ClosTron-targeted mutagenesis.Methods Mol. Biol.646165182. 10.1007/978-1-60327-365-7_11

  • 45

    HeapJ. T.PenningtonO. J.CartmanS. T.CarterG. P.MintonN. P. (2007). The ClosTron: a universal gene knock-out system for the genus Clostridium.J. Microbiol. Methods70452464. 10.1016/j.mimet.2007.05.021

  • 46

    HeapJ. T.PenningtonO. J.CartmanS. T.MintonN. P. (2009). A modular system for Clostridium shuttle plasmids.J. Microbiol. Methods787985. 10.1016/j.mimet.2009.05.004

  • 47

    HillerK.HangebraukJ.JagerC.SpuraJ.SchreiberK.SchomburgD. (2009). MetaboliteDetector: comprehensive analysis tool for targeted and nontargeted GC/MS based metabolome analysis.Anal. Chem.8134293439. 10.1021/ac802689c

  • 48

    HoT. D.EllermeierC. D. (2011). PrsW is required for colonization, resistance to antimicrobial peptides, and expression of extracytoplasmic function sigma factors in Clostridium difficile.Infect. Immun.7932293238. 10.1128/IAI.00019-11

  • 49

    HoT. D.EllermeierC. D. (2015). Ferric uptake regulator fur control of putative iron acquisition systems in Clostridium difficile.J. Bacteriol.19729302940. 10.1128/JB.00098-15

  • 50

    HoT. D.WilliamsK. B.ChenY.HelmR. F.PophamD. L.EllermeierC. D. (2014). Clostridium difficile extracytoplasmic function sigma factor sigmaV regulates lysozyme resistance and is necessary for pathogenesis in the hamster model of infection.Infect. Immun.8223452355. 10.1128/IAI.01483-13

  • 51

    HowlettR.AnttonenK.ReadN.SmithM. C. M. (2018). Disruption of the GDP-mannose synthesis pathway in Streptomyces coelicolor results in antibiotic hyper-susceptible phenotypes.Microbiology164614624. 10.1099/mic.0.000636

  • 52

    HuangW.WilksA. (2017). Extracellular heme uptake and the challenge of bacterial cell membranes.Annu. Rev. Biochem.86799823. 10.1146/annurev-biochem-060815-014214

  • 53

    HussainH. A.RobertsA. P.MullanyP. (2005). Generation of an erythromycin-sensitive derivative of Clostridium difficile strain 630 (630Deltaerm) and demonstration that the conjugative transposon Tn916DeltaE enters the genome of this strain at multiple sites.J. Med. Microbiol.54137141. 10.1099/jmm.0.45790-0

  • 54

    JacksonS.CalosM.MyersA.SelfW. T. (2006). Analysis of proline reduction in the nosocomial pathogen Clostridium difficile.J. Bacteriol.18884878495. 10.1128/JB.01370-06

  • 55

    KabischU. C.GrantzdorfferA.SchierhornA.RucknagelK. P.AndreesenJ. R.PichA. (1999). Identification of D-proline reductase from Clostridium sticklandii as a selenoenzyme and indications for a catalytically active pyruvoyl group derived from a cysteine residue by cleavage of a proprotein.J. Biol. Chem.27484458454. 10.1074/jbc.274.13.8445

  • 56

    KatzianerD. S.YanoT.RubinH.ZhuJ. (2014). A high-throughput small-molecule screen to identify a novel chemical inhibitor of Clostridium difficile.Int. J. Antimicrob. Agents446973. 10.1016/j.ijantimicag.2014.03.007

  • 57

    KhanA.SinghP.SrivastavaA. (2018). Synthesis, nature and utility of universal iron chelator - Siderophore: a review.Microbiol. Res.212213, 103111. 10.1016/j.micres.2017.10.012

  • 58

    KimJ.DarleyD.SelmerT.BuckelW. (2006). Characterization of (R)-2-hydroxyisocaproate dehydrogenase and a family III coenzyme a transferase involved in reduction of L-leucine to isocaproate by Clostridium difficile.Appl. Environ. Microbiol.7260626069. 10.1128/AEM.00772-06

  • 59

    KortmanG. A.RaffatelluM.SwinkelsD. W.TjalsmaH. (2014). Nutritional iron turned inside out: intestinal stress from a gut microbial perspective.FEMS Microbiol. Rev.3812021234. 10.1111/1574-6976.12086

  • 60

    LaneD. J. R.BaeD. H.SiafakasA. R.Suryo RahmantoY.Al-AkraL.JanssonP. J.et al (2018). Coupling of the polyamine and iron metabolism pathways in the regulation of proliferation: mechanistic links to alterations in key polyamine biosynthetic and catabolic enzymes.Biochim. Biophys. Acta186427932813. 10.1016/j.bbadis.2018.05.007

  • 61

    LangmeadB.SalzbergS. L. (2012). Fast gapped-read alignment with Bowtie 2.Nat. Methods9357359. 10.1038/nmeth.1923

  • 62

    LassekC.BurghartzM.Chaves-MorenoD.OttoA.HentschkerC.FuchsS.et al (2015). A metaproteomics approach to elucidate host and pathogen protein expression during catheter-associated urinary tract infections (CAUTIs).Mol. Cell. Proteomics149891008. 10.1074/mcp.M114.043463

  • 63

    LeeJ. Y.JanesB. K.PassalacquaK. D.PflegerB. F.BergmanN. H.LiuH.et al (2007). Biosynthetic analysis of the petrobactin siderophore pathway from Bacillus anthracis.J. Bacteriol.18916981710. 10.1128/JB.01526-06

  • 64

    LeedsJ. A.SachdevaM.MullinS.BarnesS. W.RuzinA. (2014). In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin.J. Antimicrob. Chemother.694144. 10.1093/jac/dkt302

  • 65

    LessaF. C.MuY.BambergW. M.BeldavsZ. G.DumyatiG. K.DunnJ. R.et al (2015). Burden of Clostridium difficile infection in the United States.N. Engl. J. Med.372825834. 10.1056/NEJMoa1408913

  • 66

    LiH.HandsakerB.WysokerA.FennellT.RuanJ.HomerN.et al (2009). The sequence alignment/map format and SAMtools.Bioinformatics2520782079. 10.1093/bioinformatics/btp352

  • 67

    LovittR.KellD. B.MorrisG. J. (1986). Proline reduction by Clostridium sporogenes is coupled to vectorial proton ejection.FEMS Microbiol. Lett.36269273. 10.1111/j.1574-6968.1986.tb01708.x

  • 68

    LundE. K.WharfS. G.Fairweather-TaitS. J.JohnsonI. T. (1999). Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers.Am. J. Clin. Nutr.69250255. 10.1093/ajcn/69.2.250

  • 69

    MandinP.ChareyreS.BarrasF. (2016). A regulatory circuit composed of a transcription factor, IscR, and a regulatory RNA, RyhB, controls Fe-S cluster delivery.mBio7:e0096616. 10.1128/mBio.00966-16

  • 70

    MannH. B.WhitneyD. R. (1947). On a test whether one of the two random variables is stochastically larger than the other.Ann. Math. Stat.185060. 10.1214/aoms/1177730491

  • 71

    McBrideS. M.SonensheinA. L. (2011). The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile.Microbiology15714571465. 10.1099/mic.0.045997-0

  • 72

    MinJ.LinD.ZhangQ.ZhangJ.YuZ. (2012). Structure-based virtual screening of novel inhibitors of the uridyltransferase activity of Xanthomonas oryzae pv. oryzae GlmU.Eur. J. Med. Chem.53150158. 10.1016/j.ejmech.2012.03.051

  • 73

    MishraA. K.KrumbachK.RittmannD.BattS. M.LeeO. Y.DeS.et al (2012). Deletion of manC in Corynebacterium glutamicum results in a phospho-myo-inositol mannoside- and lipoglycan-deficient mutant.Microbiology15819081917. 10.1099/mic.0.057653-0

  • 74

    MockJ.ZhengY.MuellerA. P.LyS.TranL.SegoviaS.et al (2015). Energy conservation associated with ethanol formation from H2 and CO2 in Clostridium autoethanogenum involving electron bifurcation.J. Bacteriol.19729652980. 10.1128/JB.00399-15

  • 75

    MonotM.Boursaux-EudeC.ThibonnierM.VallenetD.MoszerI.MedigueC.et al (2011). Reannotation of the genome sequence of Clostridium difficile strain 630.J. Med. Microbiol.6011931199. 10.1099/jmm.0.030452-0

  • 76

    Neumann-SchaalM.HofmannJ. D.WillS. E.SchomburgD. (2015). Time-resolved amino acid uptake of Clostridium difficile 630Deltaerm and concomitant fermentation product and toxin formation.BMC Microbiol.15:281. 10.1186/s12866-015-0614-2

  • 77

    NussA. M.HerovenA. K.WaldmannB.ReinkensmeierJ.JarekM.BeckstetteM.et al (2015). Transcriptomic profiling of Yersinia pseudotuberculosis reveals reprogramming of the Crp regulon by temperature and uncovers Crp as a master regulator of small RNAs.PLoS Genet.11:e1005087. 10.1371/journal.pgen.1005087

  • 78

    PatinD.BaylissM.Mengin-LecreulxD.OystonP.BlanotD. (2015). Purification and biochemical characterisation of GlmU from Yersinia pestis.Arch. Microbiol.197371378. 10.1007/s00203-014-1065-0

  • 79

    PeltierJ.CourtinP.El MeoucheI.Catel-FerreiraM.Chapot-ChartierM. P.LemeeL.et al (2013). Genomic and expression analysis of the vanG-like gene cluster of Clostridium difficile.Microbiology15915101520. 10.1099/mic.0.065060-0

  • 80

    PerutkaJ.WangW.GoerlitzD.LambowitzA. M. (2004). Use of computer-designed group II introns to disrupt Escherichia coli DExH/D-box protein and DNA helicase genes.J. Mol. Biol.336421439. 10.1016/j.jmb.2003.12.009

  • 81

    PeyraudR.KieferP.ChristenP.MassouS.PortaisJ. C.VorholtJ. A. (2009). Demonstration of the ethylmalonyl-CoA pathway by using 13C metabolomics.Proc. Natl. Acad. Sci. U.S.A.10648464851. 10.1073/pnas.0810932106

  • 82

    PinskeC.SawersR. G. (2016). Anaerobic formate and hydrogen metabolism.Ecosal Plus7. 10.1128/ecosalplus.ESP-0011-2016

  • 83

    PizarroF.AmarM.StekelA. (1987). Determination of iron in stools as a method to monitor consumption of iron-fortified products in infants.Am. J. Clin. Nutr.45484487. 10.1093/ajcn/45.2.484

  • 84

    PorcheronG.DozoisC. M. (2015). Interplay between iron homeostasis and virulence: Fur and RyhB as major regulators of bacterial pathogenicity.Vet. Microbiol.179214. 10.1016/j.vetmic.2015.03.024

  • 85

    ReisR. A. G.CalilF. A.FelicianoP. R.PinheiroM. P.NonatoM. C. (2017). The dihydroorotate dehydrogenases: past and present.Arch. Biochem. Biophys.632175191. 10.1016/j.abb.2017.06.019

  • 86

    Rosinski-ChupinI.SoutourinaO.Martin-VerstraeteI. (2014). Riboswitch discovery by combining RNA-seq and genome-wide identification of transcriptional start sites.Methods Enzymol.549327. 10.1016/B978-0-12-801122-5.00001-5

  • 87

    RudolphG.HenneckeH.FischerH. M. (2006). Beyond the Fur paradigm: iron-controlled gene expression in rhizobia.FEMS Microbiol. Rev.30631648. 10.1111/j.1574-6976.2006.00030.x

  • 88

    SantosJ. A.PereiraP. J.Macedo-RibeiroS. (2015). What a difference a cluster makes: the multifaceted roles of IscR in gene regulation and DNA recognition.Biochim. Biophys. Acta185411011112. 10.1016/j.bbapap.2015.01.010

  • 89

    SchroderI.JohnsonE.de VriesS. (2003). Microbial ferric iron reductases.FEMS Microbiol. Rev.27427447. 10.1016/S0168-6445(03)00043-3

  • 90

    ShafaatH. S.RudigerO.OgataH.LubitzW. (2013). [NiFe] hydrogenases: a common active site for hydrogen metabolism under diverse conditions.Biochim. Biophys. Acta18279861002. 10.1016/j.bbabio.2013.01.015

  • 91

    ShahP.SwiatloE. (2008). A multifaceted role for polyamines in bacterial pathogens.Mol. Microbiol.68416. 10.1111/j.1365-2958.2008.06126.x

  • 92

    SharmaR.KhanI. A. (2017). Mechanism and potential inhibitors of GlmU: a novel target for antimicrobial drug discovery.Curr. Drug Targets1815871597. 10.2174/1389450117666160502152011

  • 93

    SmithC. A.WantE. J.O’MailleG.AbagyanR.SiuzdakG. (2006). XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification.Anal. Chem.78779787. 10.1021/ac051437y

  • 94

    SticklandL. H. (1934). Studies in the metabolism of the strict anaerobes (genus Clostridium): the chemical reactions by which Cl. sporogenes obtains its energy.Biochem. J.2817461759. 10.1042/bj0281746

  • 95

    TautenhahnR.BottcherC.NeumannS. (2008). Highly sensitive feature detection for high resolution LC/MS.BMC Bioinformatics9:504. 10.1186/1471-2105-9-504

  • 96

    ThomeR.GustA.TociR.MendelR.BittnerF.MagalonA.et al (2012). A sulfurtransferase is essential for activity of formate dehydrogenases in Escherichia coli.J. Biol. Chem.28746714678. 10.1074/jbc.M111.327122

  • 97

    TremblayP. L.ZhangT.DarS. A.LeangC.LovleyD. R. (2012). The Rnf complex of Clostridium ljungdahlii is a proton-translocating ferredoxin:NAD+ oxidoreductase essential for autotrophic growth.mBio4:e0040612. 10.1128/mBio.00406-12

  • 98

    TroxellB.HassanH. M. (2013). Transcriptional regulation by Ferric Uptake Regulator (Fur) in pathogenic bacteria.Front. Cell. Infect. Microbiol.3:59. 10.3389/fcimb.2013.00059

  • 99

    VasilevaD.JanssenH.HonickeD.EhrenreichA.BahlH. (2012). Effect of iron limitation and fur gene inactivation on the transcriptional profile of the strict anaerobe Clostridium acetobutylicum.Microbiology15819181929. 10.1099/mic.0.056978-0

  • 100

    VizcainoJ. A.CsordasA.Del-ToroN.DianesJ. A.GrissJ.LavidasI.et al (2016). 2016 update of the PRIDE database and its related tools.Nucleic Acids Res.44:11033. 10.1093/nar/gkw880

  • 101

    WeghoffM. C.BertschJ.MullerV. (2015). A novel mode of lactate metabolism in strictly anaerobic bacteria.Environ. Microbiol.17670677. 10.1111/1462-2920.12493

  • 102

    WolfJ.StarkH.FafenrotK.AlbersmeierA.PhamT. K.MullerK. B.et al (2016). A systems biology approach reveals major metabolic changes in the thermoacidophilic archaeon Sulfolobus solfataricus in response to the carbon source L-fucose versus D-glucose.Mol. Microbiol.102882908. 10.1111/mmi.13498

  • 103

    WuX.HurdleJ. G. (2014). The Clostridium difficile proline racemase is not essential for early logarithmic growth and infection.Can. J. Microbiol.60251254. 10.1139/cjm-2013-0903

  • 104

    ZechH.TholeS.SchreiberK.KalhoferD.VogetS.BrinkhoffT.et al (2009). Growth phase-dependent global protein and metabolite profiles of Phaeobacter gallaeciensis strain DSM 17395, a member of the marine Roseobacter-clade.Proteomics936773697. 10.1002/pmic.200900120

  • 105

    ZhangW.MaJ.ZangC.SongY.LiuP. (2011). The fur transcription regulator and fur-regulated genes in Clostridium botulinum A ATCC 3502.J. Biomed. Biotechnol.2011:934756. 10.1155/2011/934756

  • 106

    ZhouP.ChenY.LuQ.QinH.OuH.HeB.et al (2018). Cellular metabolism network of Bacillus thuringiensis related to erythromycin stress and degradation.Ecotoxicol. Environ. Saf.160328341. 10.1016/j.ecoenv.2018.05.048

Summary

Keywords

Fur, iron regulation, metabolism, iron transport, cell wall, polyamine

Citation

Berges M, Michel A-M, Lassek C, Nuss AM, Beckstette M, Dersch P, Riedel K, Sievers S, Becher D, Otto A, Maaß S, Rohde M, Eckweiler D, Borrero-de Acuña JM, Jahn M, Neumann-Schaal M and Jahn D (2018) Iron Regulation in Clostridioides difficile. Front. Microbiol. 9:3183. doi: 10.3389/fmicb.2018.03183

Received

24 September 2018

Accepted

10 December 2018

Published

24 December 2018

Volume

9 - 2018

Edited by

George Grant, University of Aberdeen, United Kingdom

Reviewed by

Paul Edward Carlson, United States Food and Drug Administration, United States; Isabelle Martin-Verstraete, Paris Diderot University, France; Jiri Dresler, Military Medical Agency of Czech Armed Forces, Czechia

Updates

Copyright

*Correspondence: Dieter Jahn,

These authors have contributed equally to this work

This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics